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XIX 
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1 Theoretical Background 
1.1 What is Glycobiology? 
The term “carbohydrate” was first used over a 100 years ago to label molecules of 
the sum formula (CH2O)n. Today this term also includes carbohydrate derivatives and 
refers to the whole class of molecules. Other names for carbohydrates are 
saccharides, sugars or glycans. The term “saccharide” was derived from the ancient 
Greek word sakhar meaning sugar or sweetness. In the 19th century, Emil Fischer 
elucidated the structure of the first monosaccharide, glucose, which was also called 
dextrose after Kekulé due to its ability to refract polarised light. This was the 
development of chirality (from the greek “cheir” meaning “hand”), i.e. the 
differentiation between the D (dexter meaning “right”)- and L (laevus meaning “left”)-
forms of carbohydrates. But science was still far from realising the true biological 
impact of carbohydrates on living organisms. 
In 1953 Watson and Crick discovered the helix structure of the DNA which was a 
major breakthrough for biological sciences (Watson et al., 1953). Since then, more 
and more “molecules of life” were discovered and their impact on the biochemical 
properties of cells and whole organisms was investigated. The central dogma is that 
DNA is transcribed into RNA which is subsequently translated into proteins. 
 
 
Figure 1 The increasing level of complexity of the “molecules of life” from DNA, 
to RNA, proteins and glycans. The biosynthesis and transfer of glycans are not 
template-based. 
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This unidirectional theory became more and more perforated as transcriptional and 
translational control and regulation mechanisms were discovered. Furthermore, 
complex co- and posttranslational modifications like glycosylation were identified 
which made our picture of a cell more complete but also significantly more 
complicated. The dynamic or microheterogeneity of the glycosylation mechanism is a 
great challenge for scientists these days. What makes glycobiology even more 
challenging is the diversity of carbohydrates. The possible structure of an 
oligosaccharide far exceeds the complexity of DNA and even proteins. The degree of 
polymerisation, the linkage type and anomeric state of carbohydrates are the factors 
which make them so diverse. Fortunately for glycobiologists, nature uses limited 
monosaccharide resources and linkage types.  
 
1.2 Natural bioactive carbohydrate structures 
Oligosaccharides are crucial for the development and differentiation of cells (Ungar, 
2009). Glycoconjugates are involved in processes like inflammation, cell-cell 
signalling, cell differentiation and infections. These interactions of cells with their 
environment require accessible carbohydrate patterns on the surface of the cells. 
This so-called glycocalyx covers the surface of every eukaryotic cell.  
Major classes of glycosylation patterns are N- and O-glycosylation of proteins, 
glycosaminoglycans, glycophospholipids and glycosphingolipids. N-glycosylation 
occurs at an asparagine residue of a protein which is part of an N-X-S/T sequon 
where X can be any amino acid except proline (Bause, 1983; Jones et al., 2005). 
However, this is a necessary but not a sufficient condition. It is estimated that 
approximately 90 % of the sequons are glycosylated. Glycosylation ensures and 
even accelerates proper protein folding (Hanson et al., 2009). Unfortunately, no motif 
has yet been identified for the O-glycosylation mechanism. O-glycans are mostly of 
lower molecular weight than the N-glycosylation patterns. In glycophospholipids, 
carbohydrates function as a bridge between phophatidylinositol and 
phosphoethanolamine. The latter is coupled to the C-terminus of a glycoprotein by an 
amide bond which anchors the glycoprotein in a cell membrane. Glycosphingolipids 
or simply glycolipids are glycosylated fatty acids carrying a long-chain amino alcohol, 
3 
e.g. sphingosin (figure 2). Glycoproteins as well as glycolipids form the glycocalyx on 
the surface of a cell. 
 
 
Figure  2 Structure of the glycolipid galactosylceramide and aromatic fatty acyl 
chain analogues. 
 
In the following paragraphs, two examples of cell surface glycans are introduced 
which represent the impact of the monosaccharide structure and the linkage type 
between two monosaccharides. The first example is the human blood type. The 
structures of the blood types A and B are highly similar except of one N-linked acetyl 
group of the terminal galactose unit (figure 3). The blood type 0 misses the terminal 
galactose or N-acetylgalactosamine, respectively. As it is commonly known, this 
small change in the structure of the tetrasaccharide has a dramatic effect. The 
immune system recognises each structure as “self” or “non-self” and induces 
inflammation against non-self glycosylation patterns 
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Figure 3 Carbohydrate structures of A) blood type A with terminal galactosamine, 
B) blood type B with terminal galactose. R is a cell surface protein or ceramide. 
 
One recent topic concerning oligosaccharide structures with terminal sialic acids is 
flu. Bird flu (H5N1) and swine flu (H1N1) are termed after different variations of 
hemagglutinin (H) and neuraminidase (N). Hemagglutinin binds to terminal sialic 
acids of cells which are target for infection processes (Kunisaki et al., 2009). The 
binding mode of the sialic acid determines the infectiousness of the flu virus type. 
The human respiratory tract contains α-(2,6)-linked sialic acids whereas the bird flu 
virus is specific for α-(2,3) linkages (figure 4). However, a mutation of just one amino 
acid residue is required to change the specificity from α-(2,3) to α-(2,6) (Kunisaki et 
al., 2009). Moreover, swines can become infected by both types and therefore can 
act as a “mixing vessel” to eventually enhance the pathogenicity of the virus (Ding et 
al., 2009). 
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Figure 4 Glycosylation pattern of A) the α-(2,3)-linked sialic acid involved in “bird 
flu” infection and B)  the α-(2,6)-linked sialic acid involved in “swine flu” infection. 
 
1.3 Carbohydrate-active enzymes 
In contrast to the long-standing opinion that one enzyme is specific for one substrate 
or catalyses one reaction it is nowadays clear that many enzymes have a certain 
promiscuity in donor or acceptor substrate recognition. Additionally, molecular biology 
techniques like directed evolution and rational design help to create enzymes with 
new functionalities (Hancock et al., 2006; Eltis et al., 2008). It was shown that 
glycosyltransferases can transfer carbohydrates to different kinds of acceptors, e.g. 
alcohols, amino acids, lipids, proteins or other carbohydrates (Seibel et al., 2006a; 
Eltis et al., 2008; Shaikh et al., 2008). The natural promiscuity of glycosyltransferases 
already is surprisingly high. Enzyme and substrate engineering gives further access 
to tailor-made glycan products (Kim et al., 2006; Lairson et al., 2006; Seibel et al., 
2006a; Homann et al., 2009). 
Two major classes of these enzymes exist depending on their substrates: Leloir and 
non-Leloir glycosyltransferases. They are termed after the Argentinian chemist and 
Nobel-prize winner Luis Leloir. Leloir-type glycosyltransferases use nucleotide-
activated carbohydrates as substrates while non-Leloir enzymes use the energy of 
the glycosidic bond for the transfer of monosaccharides to an acceptor (figure 5). 
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Figure 5 The A) Leloir-type, nucleotide-activated and B) non-Leloir-type 
substrate sucrose for glycosyltransferases. The carbohydrate moiety shown in red 
can be a wide variety of monosaccharides, e.g. mannose, galactose or fucose. The 
similar binding energy of the glycosidic bond is indicated. 
 
1.4 Glycosyltransferases catalyse hydrolysis and transfer 
reactions 
As mentioned above, carbohydrates play a very important role both as polymers and 
short-chain oligo- or even monosaccharides with biological functions. 
Polysaccharides can act as structural motifs, energy reserve or protection against 
environmental factors (van Hijum et al., 2006; Comstock, 2009; Kline et al., 2009). 
The polysaccharides as well as the oligosaccharide structures are synthesised by 
glycosyltransferases. Two different kinds of reaction mechanisms were identified: 
The retaining and the inverting mechanism. In the two-step retaining hydrolysis 
mechanism, a nucleophile (generally glutamate or aspartate) attacks the anomeric 
C1 hydroxyl group and forms a covalent intermediate temporarely inverting the 
anomeric state. This intermediate is attacked by a water molecule again in position 
C1 and the hydrolysed carbohydrate is released under overall anomeric retention 
(figure 6). The inverting mechanism takes place in one step. The nucleophile attacks 
a proton from a water molecule and at the same time the water hydroxyl residue 
attacks the C1 carbon of the carbohydrate inverting the anomeric configuration 
(figure 7). 
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Figure 6 The double-displacement reaction mechanism of glycosyltransferases 
retaining the anomeric centre. 
 
 
Figure 7 The reaction mechanism of glycosyltransferases inverting the anomeric 
centre. 
 
Bacterial and fungal fructosyltransferases synthesise fructans by the non-Leloir 
pathway with the double-displacement retaining mechanism. Products are β-(2,6) 
linked levan or β-(2,1) linked inulin (van Hijum et al., 2006). In this process, a 
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fructosyl unit is transferred to an acceptor molecule. This can be water in case of 
hydrolysation, an oligosaccharide substrate like sucrose forming a trisaccharide or a 
polysaccharide yielding an elongated polymer. However, it remains unclear which 
mechanisms influence the stereospecificity of the reaction or hydrolysis, oligo- or 
polysaccharide formation.  
 
1.5 Determination of the kinetic parameters of an enzyme 
reaction – The kinetic model of Michaelis-Menten 
The kinetic model after Michaelis-Menten is a mathematical description of an enzyme 
reaction under some simplified conditions. Not all enzymes are following these laws, 
especially when inhibitory effects occur (Lasch, 1987). 
During an enzyme reaction, an enzyme-substrate-complex (ES) is formed. The 
substrate (S) is subsequently converted to a product (P) and dissociates from the 
enzyme (Lasch, 1987). This is described by equation 1.1. 
E + S              ES            EP            E + P
k1
k-1
k2
k-2
k3
k-3       [1.1] 
The simplification assumptions of Michaelis-Menten include no back reaction at the 
beginning of the enzyme reaction (k-2, -3 = 0) and only the measurement of the 
product formation. The result is equation 1.2. 
E + S              ES             E + P
k1
k-1
k2
        [1.2] 
The equation for the saturation hyperbola of the Michaelis-Menten ansatz is equation 
1.3. 
][
][max
SK
Sv
v
m 

           [1.3] 
The Km-value represents the substrate concentration at the point of half-maximal 
reaction velocity and contains the velocity constants from equation 1.2. The situation 
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at the point of half-saturation of the enzyme (Km) and the point of saturation (vmax) is 
illustrated in figure 8. 
 
Figure 8 Kinetics of an enzyme reaction after Michaelis-Menten. 
 
For the saturation of the enzyme the velocity of the product formation is crucial. By 
equation 1.4 the kcat is determined which describes the turnover rate of substrate 
molecules per time. 
0
max
2
E
v
kk cat            [1.4] 
For the determination of the catalytic efficiency it is assumed that [S] << Km under 
physiological conditions (1.5). 
 S
K
v
v
m








 max           [1.5] 
Equation 1.4 is solved for vmax and inserted in 1.5. 
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







m
cat
K
k
 is the catalytic efficiency. 
 
1.6 The pH-dependency of an enzyme reaction 
As enzymes consist of amino acids with different functional groups, they are 
polyelectrolytes. The result is a characteristic isoelectric point for each enzyme. At 
this point an identical number of positively and negatively charged groups are 
present. The charge depends on the surrounding medium. By a change of the pH a 
conformational change of the enzyme occurs. Because the enzyme reaction depends 
on the steric orientation of the amino acid residues there is a clear dependence on 
the pH of the environment. Statistically every five amino acid residues there is a 
functional group whose charge depends on the pH of the medium.  
Another issue is the influence of the pH on the substrate. During enzyme-substrate 
interactions ionic groups and the substrate conformation plays a crucial role for the 
activity of the enzyme. When choosing a buffer for an enzyme reaction the ions of the 
buffer must not or at least very fewly interact with the enzyme. Phosphate buffer 
systems ensure few enzyme interactions (Stoll et al., 1990). 
A plot of the pH and the enzyme activity usually looks like a bell-shaped curve with a 
maximum (Lasch, 1987). The Gauß-function is the basis for the plot (figure 9). 
 
2
2
0
w
xx c
eAyy


          [1.7] 
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Figure 9 Scheme of the pH-dependency of an enzyme reaction. 
 
1.7 The temperature-dependency of an enzyme reaction 
Analogous to chemical reactions the velocity of enzymatic reactions is generally 
increased with higher temperatures (Arrhenius, 1889). But one has to consider that 
enzymes denature rapidly at temperatures above the normal physiological conditions. 
These are temperature-dependent denaturing effects influencing the structural 
conformation of the enzyme. As a rule, an enzyme is the more temperature-sensitive 
the purer it is (Lasch, 1987). Under physiological conditions, enzymes are often 
associated with other proteins or membranes which have stabilising effects (Alberts 
et al., 1995). The temperature-dependency of the velocity constant is described by 
the Arrhenius equation (1.9).  
RT
Ea
eAk

           [1.9] 
A, Arrhenius factor; Ea, activation energy; R, gas constant and T, temperature. 
The plot shows a slow increase with a maximum of the reaction rate. When the 
temperature is further increased a denaturation of the enzyme and thus a fast 
decrease of the reaction rate occurs (figure 10). 
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Figure 10 The temperature-dependency of an enzyme reaction. 
 
1.8 En route to tailor-made oligosaccharides 
1.8.1 Tailor-made carbohydrates by enzyme engineering 
Many enzymes have been targets for directed evolution and rational design 
approaches to enhance their temperature- or pH-stability, to perform the catalysis of 
a novel reaction as well as the acceptance of a new substrate. The crucial point for 
the success of these strategies is the screening system. According to the so-called 
first law of directed evolution “You get what you screen for” (Schmidt-Dannert et al., 
1999) the resulting enzyme variants can have unexpected properties. Nevertheless, 
the strategy proved very useful in terms of novel acceptor substrates and novel 
activities of the engineered enzymes (Hancock et al., 2006; Gantt et al., 2008). 
Withers and co-workers turned a glycosidase into a glycosynthase or a 
glycothiosynthase, respectively (Hancock et al., 2006). The group of Fairbanks 
engineered an endo-β-N-acetylglucosaminidase to act as an 
oligosaccharyltransferase (Heidecke et al., 2008). 
The strategy of directed evolution includes the creation of as many mutants as 
suitable. Techniques are error-prone polymerase chain reaction (epPCR) or the use 
of DNA-intercalating chemicals such as nitrous acid or hydroxylamine. The resulting 
enzyme variants are screened and the positive ones are isolated. The elucidation of 
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the protein structure as well as the biochemical data of the chosen variants may help 
to explain the effect of amino acid mutations. With the structure of desired variants at 
hand, rational design may follow the directed evolution. In this work, we combined the 
techniques of directed evolution and rational design to create variants of the 
fructosyltransferase from B. megaterium in order to synthesise tailor-made 
oligosaccharides (figure 11). 
 
 
Figure 11 Combined directed evolution and screening cycle. Structural biology 
permits rational enzyme design. 
 
1.8.2 Tailor-made carbohydrates by substrate engineering 
The growing impact of chemical biology is not surprising considering the success of 
engineered substrates over the very recent years. Glycosyltransferases accept a 
bunch of modified natural substrate analogues sometimes even keeping their wild-
type activity (Fazio et al., 2002; Perez et al., 2007; Lairson et al., 2008). Bacterial 
glycosyltransferases like the fructosyltransferase from A. niger readily synthesises 1-
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kestose and 1-nystose analogues with sucrose analogues as substrates (Zuccaro et 
al., 2008). The engineered fructosyltransferase from B. subtilis synthesises 6-kestose 
and 6-nystose analogues with the same substrates (Beine et al., 2008). Short-chain 
oligofructosides are known as prebiotics with beneficial effects on the human 
intestinal flora (Yun, 1996; Saavedra et al., 2002; Boehm et al., 2004; Hirayama et 
al., 2005; Comstock, 2009). Also the L-forms of various sucrose analogues are 
accepted by the levanucrase SacB from B. subtilis (figure 12; Seibel et al., 2006a). 
Engineered substrates with thio-functionalities offer further chemical modification 
steps (Pachamuthu et al., 2006; Hellmuth et al., 2007).  
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Figure 12 Possible chemo-enzymatic synthesis of various oligosaccharide 
structures (Stoppok et al., 1995; Seibel et al., 2006b; van Hijum et al., 2006). 
16 
1.9 Isomerases as tools for controlling the linkage type of 
oligosaccharides 
Sucrose isomerases convert sucrose (α-D-glucopyranosyl-β-(1,2)-D-fructofuranoside) 
to the sucrose analogues isomaltulose (α-D-glucopyranosyl-β-D-(1,6)-
fructofuranoside, also referred to as the commercial name palatinose) (yield up to 75-
85 %) or trehalulose (α-D-glucopyranosyl-β-(1,1)-D–fructofuranoside, yield up to 90 
%) depending on the bacterial strain and the reaction conditions (figure 13; 
Cheetham, 1984; Nagai et al., 1994; Veronese et al., 1998; Zhang et al., 2003; Wu et 
al., 2005). Palatinose (synonym for isomaltulose) is an established commercial 
product. It is used as a substitute for sucrose beneficial in the treatment of diabetics 
and sports in food and drinks (Lina et al., 2002). The structures of PalI, an 
isomaltulose synthase from Klebsiella sp. strain LX3 (Zhang et al., 2003), MutB, a 
trehalulose synthase from Pseudomonas mesoacidophila MX-45 (Ravaud et al., 
2005; Ravaud et al., 2007) and SmuA, a sucrose isomerase from Protaminobacter 
rubrum have been solved (Ravaud et al., 2009). Sucrose isomerases are classified 
as GH 13 retaining glycoside hydrolysases according to CAZy database (Cantarel et 
al., 2009). Other enzymes of this class are starch-acting, branching enzymes and 
amylase for example. They are glycosidases containing a highly conserved active 
site and act via a double-displacement mechanism forming a glycosyl intermediate 
(Davies et al., 1995; Mosi et al., 1997; Yoshioka et al., 1997; Uitdehaag et al., 1999; 
Jensen et al., 2004). The catalytic triad of the sucrose isomerase from P. rubrum 
consists of the amino acid residues D214, E268 and E342 (Ravaud et al., 2009). An 
aromatic clamp with impact on the hydrolysis versus transfructosylation activity has 
been described for GH 5 enzymes, i.e. the fungal exo-glucanase subfamily (Cutfield 
et al., 1999) and an endocellulase (Ducros et al., 1995). In the sucrose isomerase 
from P. rubrum it is formed by the amino acid residues F270 and F294 (Ravaud et 
al., 2009). 
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Figure 13 Sucrose isomerase (SI) activity depending on the bacterial strain. 
Sucrose is converted predominantly to isomaltulose (SI from Protaminobacter 
rubrum) or trehalulose (SI from Pseudomonas mesoacidophila; Zhang et al., 2003; 
Ravaud et al., 2006; Ravaud et al., 2007). 
 
1.10  Physiological effects of novel oligosaccharides  
1.10.1 Applications of oligo- and polysaccharides 
Oligo- and polysaccharides are already used frequently in many commercial 
products, e.g. cosmetics, functional food and medicine. Various polysaccharides like 
hyaluronan, galactan and oligofructose are used in cosmetic products. Functional 
food with beneficial effect for the intestinal flora includes inulin, oligofructose and 
isomaltose for example. The isomers of sucrose (trehalulose and isomaltulose) are 
sweet but non-cariogenic and metabolised without the release of glucose. The 
pharma industry currently investigates the bioengineering of oligosaccharides for 
various applications (table 1). One recent example is the synthesis of erythropoietin 
(Epo), a glycosylated cytokine involved in the control of the red blood cell population, 
with the exact human glycosylation pattern (Sinclair et al., 2005; Kim et al., 2008). 
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Table 1 Chemo-enzymatically synthesised carbohydrate structures and their 
possible applications. 
Oligosaccharide Synthesis (potential) 
Application 
Structure 
Sucrose analogue Donor: Sucrose 
Acceptor: 
Glycopyranosyl 
residue 
Fructosyltransferase 
SacB from Bacillus 
subtilis or megaterium 
Nutrition (low 
caloric, non-
caryogenic 
sweetener, 
prebiotic)  
 
Fructo-
oligosaccharides 
Donor: Sucrose 
analogue 
Acceptor: Sucrose 
analogue 
β-fructofuranosidase 
Suc1 from Aspergillus 
niger 
Nutrition 
(prebiotic), 
Pharma 
(immuno-
stimulation) 
 
Isomaltose Donor: Sucrose 
Acceptor: Glucose 
Lactobacillus reuteri 
GTFR variant S628D 
Nutrition (low 
caloric 
sweetener), 
cosmetic 
 
Novel α–(1,3) 
glucan with α–
(1,6) branches 
Donor: Sucrose 
Acceptor: Glucan 
Lactobacillus reuteri 
GTFR variant 
R624G/V630I/D717A 
New material 
(surfactant), 
cosmetic 
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Gal-Tn analogue Donor: UDP-Gal 
Acceptor: 1-allyl-2-N-
acetyl-glucosamine 
β-(1,4) 
galactosyltransferase 
from bovine milk 
Medicine 
(vaccine) 
 
LeX analogue Donor: β-L-1-thio-
fucose 
Acceptor: 1-allyl-6-p-
toluenesulfonyl-Gal-Tn 
DMF, 80° C 
Medicine 
(vaccine) 
 
 
 
1.10.2 Carbohydrates as prebiotics 
Lactobacilli and Bifidobacteria are known for their beneficial effects in the human 
intestinal tract (Yun, 1996). In functional food like cereals and yoghurt they are 
already applicated to humans. Their growth is stimulated by prebiotics like 
oligofructose and inulin which are also components of functional food. Lactobacilli are 
micro-aerophile, rod-shaped cells found in pairs or short chains (figure 14). They 
grow at temperatures of up to 45 °C and acidic conditions (pH 4-5). They were 
isolated from milk, wheat, meat and fish. In humans, they are found in the gut area. 
Lactobacilli metabolise lactose and form lactic acid in a homofermentative process. 
Some heterofermentative strains produce ethanol, carbon dioxide and acetic acid. 
Lactobacilli help to improve the intestinal function and prevent unwanted bacteria 
from growth by creating an acidic environment thus increasing their own population. 
In the intestinal tract, Lactobacilli synthesise the beneficial metabolites niacin, folic 
acid and pyridoxine (Schlegel, 1992). 
Bifidobacteria are anaerobic intestinal rod-shaped bacteria. They metabolise 
carbohydrates like glucose and form acetic acid and lactic acid (Schlegel, 1992). 
Bifidobacteria like the Lactobacilli are considered as beneficial for the gut function 
and human health. 
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Figure  14 On the left: Rod-shaped Lactobacilli forming chains are shown in 
purple. The right picture shows Bifidobacteria. 
 
1.10.3 Small proteins as immuno-stimulating agents - 
Characteristics of cytokines and chemokines 
Inflammation processes are essential for the viability of a host organism attacked by 
bacteria, viruses or other pathogens. These hostile organisms carry surface agents 
recognised by the host as non-self. The factors which trigger cytokines and 
inflammation have been investigated thoroughly over the last decade but still the 
process is yet not fully understood. Cytokines are proteins of a small molecular 
weight (< 30 kDa) synthesised by T-cells, macrophages and monocytes. The 
molecular weight of chemokines is in the range of 8-12 kDa. Chemokines are 
synthesised by a broad variety of cells, not only involved in blood coagulation and 
hematopoeity processes as suggested previously. For a detailed characterisation of 
chemokines and their physiological effects see the reviews by Rollins and Springer 
(Springer, 1994; Rollins, 1997). Some are introduced in table 2 and figures 15 and 
16. All chemokines are structurally homologue and they affect the G-protein-coupled 
7-helix-type receptor (Paul, 2008). Cytokines can be triggered by lipopolysaccharides 
on the surface of Gram-negative bacteria (Ulevitch et al., 1995; Stevens, 1997) or 
capsular polysaccharides and lipoteichoic acid from Gram-positive species 
(Standiford et al., 1994; Massion et al., 1995; Soell et al., 1995; Miller et al., 1996a; 
Miller et al., 1996b; Yao et al., 1997). Recent studies suggest a connection between 
auto-immune diseases and mutations in glycosyltransferase genes leading to 
defections in the N-glycosylation pattern of proteins. In mice, the knock-out of a 
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mannosidase (αM-II) involved in the trimming of the N-glycosylation patterns of 
glycoproteins in the Golgi yields exposed hybrid-type mannose patterns. These are 
recognised as non-self and act as inducers for innate immune responses under the 
release of cytokines and chemokines, e.g. MCP-1 (Green et al., 2007). Another 
investigation of immune-stimulating effects of carbohydrate structures is the 
incubation of the probiotic E. coli strain Nissle 1917 with human epithelial colorectal 
adenocarcinoma (Caco-2) cells. An increase in the release of cytokines and 
chemokines, e.g. MCP-1 and IL-8, was observed. It was shown that the triggering of 
the cytokine and chemokine release is due to a capsular polysaccharide (K5) on the 
surface of E. coli Nissle 1917 (Hafez et al., 2009). 
IL-8, representing the CXC-class of chemokines, is an ubiqitious chemokine 
synthesised by monocytes, T lymphocytes, neutrophils, fibroblasts, endothelial cells, 
and epithelial cells (Rollins, 1997). Two cysteine residues form disulfide bridges at its 
amino-terminal end separated by one amino acid residue (CXC motif). After the 
induction of IL-8 expression during inflammation, IL-8 is stored for days in Weibel-
Palade bodies of endothelial cells along with other proteins like the von-Willebrand 
factor involved in blood coagulation (Sadler, 1998; Wolff et al., 1998). This is 
considered as a memory function of the inflammation process. Upon repeated 
inflammatory stimulation, IL-8 can be released from the Weibel-Palade bodies 
without de novo synthesis. Recent findings include the stimulation of IL-8 during 
integrin-mediated infection of HEp-2 cells by Yersinia (Uliczka et al., 2009). 
MCP-1 (monocyte chemoattractant protein 1) is a potent chemoattractor for 
monocytes in vitro (500 pmol l-1). It represents the chemokine class CC because of 
two adjacent cysteine residues at its amino-terminal end. MCP-1 induces the 
expression of integrins for chemotaxis during monocyte migration processes (Jiang et 
al., 1992; Vaddi et al., 1994). T lymphocytes like CD4 are a target of MCP-1 (Carr et 
al., 1994). MCP-1 is one factor responsible for the release of histamine by basophils 
(Alam et al., 1992; Bischoff et al., 1992; Kuna et al., 1992). 
 
 
 
 
22 
Table 2 Cytokine and chemokine families and receptor types. Adapted from 
Callard and Gearing, Cytokine Facts Book (Callard et al., 1994). 
Family Members Receptor type 
 
Hematopoietins 
(4 α-helical bundles) 
 
IL-2, IL-3, IL-4, IL-5, Il-6, 
IL-7, IL-9, IL-13, G-CSF, 
GM-CSF, CNTF, OSM, 
LIF, Epo 
 
IL-10, IFNα, IFNβ, IFNγ 
 
M-CSF 
 
Cytokine receptor class I 
 
 
 
Cytokine receptor class II 
 
Tyrosine kinase 
 
EGF 
(β-sheet) 
 
EGF, TGFα 
 
Tyrosine kinase 
 
β-trefoil 
 
FGFα, FGFβ 
 
IL-1α, IL-1β, IL-1Rα 
 
Split tyrosine kinase 
 
IL-1 receptor 
 
TNF 
(jelly roll motif,  
 
TNFα, TNFβ, LTβ 
 
NGF receptor 
cysteine knot) NGF 
 
TGFβ1, TGFβ2, TGFβ3 
 
PDGF, VEGF 
NGF receptor 
 
Serine/threonine kinase 
 
Tyrosine kinase 
 
Chemokines 
(triple-stranded, anti-
parallel β-sheet) 
 
IL-8, MIP-1α, MIP-1β, MIP-
2, PF-4, PBP, I-309/TCA-3, 
MCP-1, MCP-2, MCP-3, 
gIP-10 
 
Rhodopsin superfamily 
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Figure 15 Functional classification of cytokines (Mantovani et al., 2000). 
 
 
Figure 16 Dimeric structures of A) CC-class IL-8 (Clore et al., 1990) and B) CXC-
type MCP-1 (Handel et al., 1996). The monomers are shown in grey and rosé. A) The 
three β-sheets of each monomer form a plane for the two parallel α-helices. B) The 
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two subunits interact by two β-sheets (β0) forming an elongated, cylindrical-shaped 
dimer.  
 
1.11  Metabolic labelling of cell surfaces 
1.11.1 Glycan target structures 
The surface of eukaryotic cells is highly decorated with glycan structures of various 
types forming the glycocalyx (figures 17 and 18). Glycolipids and glycoproteins 
mediate cell-cell recognition and signal transduction processes. The highly diverse N-
glycosylation patterns of glycoproteins are built by a surprisingly low pool of 
monosaccharides. The complexity of the oligosaccharides results from branches and 
different linkage types of the monosaccharides.  
The carbohydrates derive from the periplasma or yield from various metabolic cellular 
processes. N-glycosylation occurs in the Endoplasmatic Reticulum (ER) and the 
Golgi. In the ER a defined glycosylation pattern is synthesised and transferred to the 
asparagine residue of a glycoprotein`s sequon Asn-X-Se/Thr. In the ER, the N-
glycosylation motif acts as a protein folding sensor. Recent findings show an even 
enhanced fold when the glycosylation pattern is correct (Hanson et al., 2009). The 
ER-N-glycosylation pattern also interacts with the calnexin/calreticulin cycle to ensure 
proper glycosylation and correct folding of the enzyme. In this process one glucose 
unit is cleft and retransferred (Totani et al., 2009). After this process of enzyme 
quality control, the glycoproteins proceed to the Golgi where further trimming of the 
glycan patterns occurs. The result is a protein with a glycosylation pattern depending 
on the cell type, environmental conditions and development state of the cell and 
organism (Ungar, 2009). The terminal units of glycoproteins are often sialic acids 
(figure 18). 
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Figure 17 Examples of N- and O-glycosylation patterns of proteins. 
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Figure 18 Glycosylation pattern of a human colon cancer cell line from the 
database of the consortium of functional glycomics 
(http://www.functionalglycomics.org). For the sign code see the figure above. 
 
1.11.2 Metabolic labelling and engineering of the cell surfaces of 
eukaryotic cell lines in vitro and in vivo 
Bertozzi and coworkers showed that functionalised carbohydrates can be 
incorporated into cells in vitro (Saxon et al., 2002; Dube et al., 2003; figure 19). This 
process works by active transporters and diffusion procedures depending on the 
modification of the carbohydrates. Acetylated sugars can easily pass the cell 
membrane whereas neuraminic acid derivatives carrying no acetylated hydroxyl 
groups enter the cell by special transporter systems (Bardor et al., 2005). Acetylated 
monosaccharides are processed by unspecific deacetylases, activated by nucleotide 
transferases and metabolised by isomerases and epimerases (Prescher et al., 2006; 
Chang et al., 2007; Codelli et al., 2008; Laughlin et al., 2008; Chang et al., 2009). 
These activated carbohydrate analogues are incorporated into the natural 
carbohydrate patterns of the cell (figure 19). Some of the modified sugars are part of 
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the glycosylated cell surface and therefore are accessible to chemical conversion 
without destruction of the cell. Depending on the modified carbohydrate added to the 
growth medium of the cell line or organism, N- or O-glycosylation patterns are 
addressed. However, the exact mechanism of incorporation remains to be 
investigated.  
The major classes of functionalised bioorthogonal monosaccharide analogues 
successfully incorporated into cells are azides and alkynes (figure 19). One chemical 
detection method is the (1,3)-dipolar cycloaddition reaction after Sharpless and 
Huisgen which proofed suitable for bioorthogonal metabolic labelling (figure 20) (Kolb 
et al., 2001; Agard et al., 2004). Alternative strategies include the modification of 
cysteine residues of proteins and the introduction of aldehyde groups on modified 
substrate analogues (Prescher et al., 2005; figure 21). 
 
 
Figure 19 The biosynthesis pathway of sialic acid. Incorporation of modified 
AcGlcNAz and its entrance in the carbohydrate metabolic process. R is an azide or 
alkyne (up to hexyne) group. ManNAc-6-kinase was described as a bottleneck for 
sterically large functional groups in position “R” (Dube et al., 2003). It was shown that 
it is also possible to enter the metabolic process at different stages, e.g. AcManNAz 
(Chang et al., 2007) or AcGlcNAz, GlcNAz, NeuNAz and NeuNHex (this thesis) can 
be used for metabolic labelling. 
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Figure 20 Reaction mechanism of the triazole formation by a (1,3)-dipolar 
cycloaddition (“click reaction”). 
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Figure 21 Possible bioorthogonal metabolic labelling reactions. a)-c) A 
metabolically incorporated carbohydrate analogue with an azide function (R-N3) can 
be coupled to a phosphine, an alkyne activated by Cu(I) or an in vivo compatible 
strain-promoted cycloaddition (Kolb et al., 2001; Baskin et al., 2007). d) A genetically 
encoded tetracysteine motif is modified with a biarsenical labelling reagent (FlAsH-
EDT2). Fluorescence is induced upon binding to recombinant proteins containing the 
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tetracysteine motif Cys-Cys-Pro-Gly-Cys-Cys; e) p-acetyl phenylalanine in response 
to the stop codon TAG during protein biosynthesis in vivo. The ketone can be 
derivatised with amino-derivatives, e.g. aminooxysaccharides (Prescher et al., 2006; 
Sletten et al., 2009). 
 
In case of the azide-alkyne “click reaction”, Cu(I) needs a ligand for its activation 
which can be [Tris(benzyl-1H-1,2,3-triazol-4-yl)-methylamine] (TBTA (Ln) (step A in 
figure 20). The functionalised alkyne is in turn activated by the Cu(I)-Ln complex and 
forms an intermediate with the nitrogen bound to R2 (B-1). The now activated azide 
performs an attack at the C-group of the alkyne coupled to R1 forming the (1,3)-
intermediate with copper as a hetero ring member (B-3). An electrophilic attac of the 
carbon in position 2 to R2-bound nitrogen forms the 5-membered triazole ring with 
ligand-activated-copper as the leaving group (C). 
The eukaryotic carbohydrate metabolism can be exploited in vivo by functionalised 
monosaccharide analogues (figure 22; Baskin et al., 2007). Recent approaches 
include the in vivo incorporation of azido-carbohydrates. Bertozzi and co-workers 
established a labelling method without the use of toxic copper by a strain-promoted 
cycloaddition using a fluorescence-labelled difluorinated cyclooctyne (DIFO, figure 
21b (Baskin et al., 2007; Laughlin et al., 2008). The multi-step labelling reaction was 
performed in zebrafish embryos with different dyes and during different states of 
development in the same embryo (Laughlin et al., 2008). The change in the 
glycosylation pattern over time shows in which glycosylation processes of the 
organism take place at which point of time (figure 23). 
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Figure 22 Metabolic labelling of cell surfaces by the incorporation of modified 
monosaccharides. They pass the membrane by diffusion (acetylated carbohydrates) 
or active transport mechanisms (Bardor et al., 2005). 
 
 
Figure 23 Adapted from Laughlin et al., 2008: Identification of temporally distinct 
glycan populations during zebrafish development using two colour labelling. 
Zebrafish embryos metabolically labelled with Ac4GalNAz from 3 to 60 h were 
reacted with DIFO-647 between 60 and 61 hours and then reacted with DIFO-488 
between 62 and 63 hours. E) Brightfield image of a ventral view of an embryo at 63 
hours. F) Single z-plane fluorescence image of E) displaying intense DIFO-488 
fluorescence but not DIFO-647 fluorescence. Scale bars are 100 mm. 
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As a further example of cell surface functionality, the cell surface functionalised with 
azido-carbohydrates was modified with phosphine-labelled single-stranded (ss) DNA 
(figure 24) (Chandra et al., 2006). By the application of defined oligonucleotides the 
labelled surface is specifically identified by fluorescence-labelled complementary 
DNA or other complementary DNA-labelled cells of the same type or another (figures 
25 and 26). In this way interactions can be studied that happen in vivo or do not 
occur naturally (Gartner et al., 2009). In one experiment, Jurkat cells were labelled 
with a fluorescent agent and assembled with cells containing the complementary 
ssDNA on their surface (figure 25). In another approach, different cell types which 
were labelled with different fluorescent molecules. First, the two populations were 
sorted by FACS and subsequently incubated with a third population which was not 
fluorescent but labelled with complementary DNA. The result is an assembly of the 
three cell types (figure 26). 
 
 
Figure 24 DNA-based cell-cell assembly. The red star label indicates a fluorescent 
marker or another cell. 
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Figure 25 Adapted from Gartner et al., 2009: Jurkat cells labelled with fluorescein-
conjugated DNA (single cell, left panel) were assembled with cells bearing a non-
fluorescent complementary strand (middle and right panel). Scale bar is 10 µm. 
 
 
 
Figure 26 Adapted from Gartner et al., 2009: Fluorescence-activated cell-sorting 
(FACS) separates cell assemblies based on their fluorescence properties. On the left 
picture Jurkat cell-based structures were isolated by FACS based on red and green 
fluorescence proportional to the number of each cell type in the cluster. Middle and 
right picture: Higher-order multicellular structure generated by incubation of the 
labelled cells with a third population of unstained Jurkat cells bearing cell surface 
oligonucleotides complementary to those on the red-stained cells. Red, Texas Red; 
green, fluorescein; scale bars, 10 µm. 
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1.12  Oligosaccharides as potential vaccines 
During the recent years there is a growing attention towards carbohydrate-based 
vaccines for infection and cancer therapies. Oligosaccharides and glycoconjugates 
like proteoglycans and glycolipids were synthesised and tested in vitro and in vivo 
with promising results. However, the major breakthrough has not been achieved yet. 
Carbohydrates alone mostly do not evoke a full immune answer. The task is to find 
the right combination regarding the aglycon and the structural presentation of the 
glycans. In this chapter some examples will be presented which are steps to future 
carbohydrate-based vaccination strategies.  
Bacteria forming biofilms play a role in a wide variety of human infection processes 
(Potera, 1999; Donlan et al., 2002). Polysaccharide-promoted intercellular adhesion 
processes are known to evoke immunogenic responses in mice (McKenney et al., 
1999; Maira-Litran et al., 2002). Anticancer vaccines were developed by a couple of 
working groups over the recent years (Dziadek et al., 2004; Buskas et al., 2005; 
Ingale et al., 2007; Wittrock et al., 2007; Westerlind et al., 2008). Some 
polysaccharides show relatively high affinities for special cell types. Heparin for 
example has a 100-fold increase in affinity towards apoptotic cells (Gebska et al., 
2002).  
Also vaccine approaches gave first promising results. The carbohydrate moiety is 
linked to an immunogenic protein like bovine serum albumine (BSA) or keyhole 
limetic hemocyanine (KLH). A concerted immune answer with immuno-globulin (Ig) 
G-release is the consequence when mice are vaccinated. But the cumulative 
stimulation of the innate and acquired immune system was successful in more cases. 
The carbohydrate units were coupled to T- and B-cell oligopeptide epitopes. 
Furthermore, different classes of cancer cell oligosaccharide patterns were coupled 
to the peptide. A globotriaosyl (Gb3) ceramide mimick and a mucin-type MUC5A-
motif were alternatingly linked to a B- and T-cell oligopeptide epitope (Zhu et al., 
2009; figure 27). The introduction of multivalent carbohydrate-protein constructs 
enhanced the immunogenicity of the vaccine. 
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Figure 27 Second generation carbohydrate-based anti-cancer vaccine with 
remarkable immuno-stimulating activity (Zhu et al., 2009). 
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2 Aim of this work 
This thesis on the crossroads of biology and chemistry aims at the combination of 
chemical and enzymatic methods for the synthesis of defined natural carbohydrate 
oligosaccharides, their analogues and their chemical functionalisation. These target 
structures may interact with proteins during infections, inflammation and other cell 
signalling and cell-cell interaction processes.  
The aim is the chemo-enzymatic synthesis of tailor-made oligosaccharides. 
Difficulties are their chemical similarity and laborious chemical synthesis. Therefore 
the chemical synthesis shall be supported and broadened by enzymatic glycosylation 
methods in order to expand the library of accessible oligosaccharide structures. 
The first aim was the identification of novel glycosyltransferases. A novel 
fructosyltransferase SacB from Bacillus megaterium was identified in the group of 
Dieter Jahn (TU Braunschweig). Another fructosyltransferase (Suc1) from Aspergillus 
niger was identified in the group of Petra Dersch (Helmholtz-Centre for Infection 
Research and TU Braunschweig). The biochemical characterisation, cloning, 
expression, purification and crystallisation were performed in cooperation with the 
two mentioned groups from the Department of Microbiology at the TU Braunschweig 
and with the groups of Dirk Heinz from the Helmholtz-Centre for Infection Research. 
These studies shall be the basis for rational design approaches in order to create 
enzyme variants with altered product spectra. The biochemical characterisation 
includes the determination of the temperature- and pH optima, the kinetic parameters 
after Michaelis and Menten (Km, kcat) and the determination and analysis of the oligo- 
and polysaccharide product spectra. They shall be analysed by thin layer 
chromatography (TLC), high-performance anion-exchange chromatography 
(HPAEC), mass spectroscopy (MS) and nuclear magnetic resonance (NMR) 
spectroscopy. 
Besides enzyme engineering, substrate engineering shall expand the diversity of 
carbohydrates to be synthesised. The established synthesis of sucrose analogues by 
the fructosyltransferase SacB from Bacillus subtilis shall be expanded to the 
fructosytransferase SacB from Bacillus megaterium. The fructosyltransferases SacB 
from B. megaterium and Suc1 from Aspergillus niger which synthesis natively short-
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chain fructo-oligosaccharides shall be characterised biochemically. They are going to 
be expressed heterologously in E. coli in case of SacB or expressed homologously in 
a genetically engineered A. niger (Suc1). They shall be purified and, as Suc1 is a 
heavily glycosylated protein, the effects of the glycosylation pattern on the activity 
and product formation of Suc1 is going to be investigated. Novel oligofructosides 
shall be synthesised by a combined action of these two fructosyltransferases. The 
products shall be characterised regarding their prebiotic and immuno-stimulating 
properties using Lactobacilli and Bifidobacteria and human epithelial colorectal 
adenocarcinoma (Caco-2) cells, respectively. An eventual growth of the beneficial gut 
bacteria indicates prebiotic activity. Four different strains of Lactobacilli (Lb. 
fructosus, Lb. plantarum, Lb. fermentum and Lb. delbrueckii) and Bifidobacterium 
lactis are going to be investigated concerning the ability to metabolise fructo-
oligosaccharides. Their growth rate on fructo-oligosaccharides of different chain 
length in a semi-defined medium with addition of the carbon source to be 
investigated shall be examined and compared. The immuno-stimulating ability of 
fructo-oligosaccharides shall be investigated by characterising the cytokine release of 
Caco-2 cells incubated in the presence of the novel oligofructosides. 
Another issue of this thesis is the control of the carbohydrate linkage type. The 
chemical control is difficult because of the chemical similarity of the carbohydrate 
hydroxyl groups. The isomerisation possibilities of novel sucrose analogues 
synthesised by the fructosyltransferase SacB from B. megaterium shall be 
investigated. Sucrose isomerases are known to form isomaltulose and/or trehalulose 
from sucrose. The sucrose isomerase SmuA from Protaminobacter rubrum, a mainly 
isomaltulose-forming enzyme, shall be investigated regarding its substrate 
promiscuity. Thus, the linkage type of our newly synthesised sucrose analogues shall 
be controlled as a further step towards tailor-made oligosaccharides. 
The last point of the thesis is the labelling of cell surfaces by functionalised 
carbohydrates. In cooperation with the group of Petra Dersch from the TU 
Braunschweig and the Helmholtz-Centre for Infection Research, the incorporation of 
chemically modified carbohydrates into the cell metabolism shall be investigated. 
These functionalised carbohydrates shall lead to modified cell surfaces containing 
glycoproteins with chemical tags. This tag has to fullfill restrictive characteristics. It 
has to be accessible for chemical modification, the chemical labelling reaction shall 
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be ideally non-toxic in order to take place in vivo and the tag has to be metabollically 
inert which is referred to as biological orthogonality. The azide-alkyne click-chemistry 
reaction shall be investigated if it is suitable for this purpose. The labelling reaction 
shall be performed with a fluorescent agent. It shall be investigated which conditions 
are suitable for the in vivo labelling. Different functionalised monosaccharides and 
different modified fluorescent agents are going to be examined in labelling human 
larynx carcinoma (HEp-2) and hamster ovary carcinoma (CHO) cells. 
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3 Materials and Methods 
3.1 Instruments 
Instrument Type Company 
Autoclave Westima Sauter 
Centrifuge, cooled J2 21 Beckman 
Rotor JA-10, JS-13 Beckman 
Clean bench Heraeus LaminAir Heraeus 
Electrophoresis device Power-phor-N anamed 
Fast Protein Liquid 
Chromatography (FPLC) 
device 
  
Pump LKB Pump P-500 Pharmacia 
Controller Liquid Chromatography 
Controller LCC-500 Plus 
Pharmacia 
Detector Biotech UV-MII Pharmacia 
Fraction collector LKB Frac-100 Pharmacia 
Column for SacB 
purification 
CM-Sepharose GE Healthcare 
Column for Suc1 
purification 
Superdex 200 GE Healthcare 
High-Performance Anion 
Exchange Liquid 
Chromatography (HPAEC) 
device 
  
Basic 
chromatography 
module 
CHB Dionex 
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Gradient pump GPM-2 Dionex 
Pre-column CarboPac PA1 , 4*50 mm Dionex 
Main column CarboPac PA1, 4*250 m Dionex 
Pulsed amperometric 
detector 
PAD-2 Dionex 
Autosampler series 200 with  
tefzel valve 
Perkin Elmer 
Rheodyne 
Thermostate Thermomix BU Braun 
Luminex system Luminex 200 Luminex 
MALDI-TOF Mass 
Spectrometry 
Ultraflex  Bruker Daltonics 
NMR  Bruker 
Photometer ultrospec 200 GE Healthcare 
Sonotrode MS72 Bandelin 
Spektrophotometer NanoDrop 
Spectrophotometer ND-
100 
peqLab Biotechnology 
Thermoshaker:  GFL 
Ultra pure water device MilliQ Millipore 
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3.2 Chemicals, media and solutions 
All chemicals, media and biological kits were ordered at Roth, NEB, Sigma-Aldrich, 
Merck, Carbosynth, Glycon, Invitrogen or Bio-Rad. 
 
3.2.1 Media for the cultivation of bacterial cells 
3.2.1.1 Medium after Luria-Bertani (LB-medium) 
 
Peptone  10 g l-1 
Yeast extract   5 g l-1 
NaCl       5 g l-1 
 
The medium was autoclaved for 20 min at 120 °C and 1 bar of overpressure. The 
antibiotics were sterilised by filtration. 
 
3.2.1.2 LB-Medium supplements 
 
Agar   15 g l-1 
Ampicillin  0.5 mM  
IPTG   0.5 mM  
 
The media containing antibiotics was cooled down to lower than 60 °C prior to 
antibiotic addition. 
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3.2.1.3 Medium after de Man, Rogosa and Sharp (MRS) 
 
Universal peptone     10.0 g l-1 
Meat extract      5.0 g l-1 
Yeast extract     5.0 g l-1 
D(+)-Glucose     20.0 g l-1 
Dipotassium hydrogen phosphate  2.0 g l-1 
Diammonium hydrogen citrate   2.0 g l-1 
Sodium acetate     5.0 g l-1 
Magnesium sulfate     0.1 g l-1 
Manganous sulfate     0.05 g l-1 
 
optional: agar     12.0 g l-1 
 
 
3.2.1.4 Semi-defined medium after Vogel (Korakli et al., 2003)  
 
NH4Cl 2 g l
-1 
Na acetate 5 g l-1 
MnSO4 0.05 g l
-1 
K2HPO4 2 g l
-1 
Yeast Nitrogen Base 
(Difco) 
5 g l-1 
Bacto Pepton (Difco) 10 g l-1 
 
addition of the 
appropriate C-source 
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3.2.2 Media for the cultivation of eukaryotic cells 
3.2.2.1 Medium for the cultivation of Caco-2 and CHO-K1 
 
RPMI-1640, Biochrom 
 add 7.5 % newborn calf serum (Invitrogen) 
 
 
3.2.2.2 Medium for the cultivation of HEp-2 
 
DMEM/Ham`s F12 (1:1), Biochrom  
 add 10 % fetal calf serum (Invitrogen) 
 
optional: ampicillin 0.5 mM 
 
 
3.2.3 Phosphate buffer after Sörensen 
 pH 5.0 pH 5.6 pH 6.0 pH 6.6 pH 7.0 pH 7.6 pH 8.0 
KH2PO4 (% v/v) 99.2 95.5 88.9 65.3 41.3 12.8   3.7 
Na2HPO4 (% v/v)   0.8   4.5 11.1 34.7 58.7 87.2 96.3 
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3.2.4 Sodiumdodecylsulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) 
 
Loading buffer  
Roti-Load, Roth 
 
10x denaturing Tris/Glycine buffer  
Tris     30.0 g l-1 
SDS     30.0 g l-1 
Glycin   144.0 g l-1 
in water. 
 
Fixing solution 
Trichloroaceticacid 20 % (w/v) 
in water 
 
Staining solution 
Solution A  
Coomassie Blue 0,2 % (w/v) 
in methanol  
Solution B  
Acetic acid  20 % (v/v) 
  Mix A and B in a ratio of 1:1. 
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Decolouration solution 
Acetic acid   10 % (v/v) 
Methanol  20 % (v/v) 
in water 
 
Prestained Protein Marker, Broad Range, New England Biolabs 
175.0  kDa MBP-ß-Galactosidase 
83.0 kDa MBP-Paramyosin 
62.0 kDa Glutarsäure Dehydrogenase 
47.5 kDa Aldolase 
32.5 kDa Triosephosphat-Isomerase 
25.0 kDa ß-Lactoglobulin A 
16.5 kDa Lysozym 
6.5 kDa Aprotinin 
 
 
3.2.5 Carbohydrate analysis by thin layer chromatography (TLC) 
 
Mobile phase 
Ethylacetate  60 % (v/v) 
Isopropanol  30 % (v/v) 
Water   10 % (v/v) 
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Developing solution 
Sulfuric acid  5 % (v/v) 
N-N   0.3 % (w/v) 
in methanol 
 
Carbohydrate standard  
Glucose  0.1 g l-1 
Fructose  0.1 g l-1 
Sucrose  0.1 g l-1 
1-Kestose  0.1 g l-1 
1-Nystose  0.1 g l-1 
 
 
3.2.6 Carbohydrate analysis by high-performance anion-exchange 
chromatography (HPAEC) 
 
Mobile phase 
NaOH (solution) 0.1 mol l-1 
 
Elution phase 
NaOH (solution) 0.1 mol l-1 
Sodium acetate 82.0 g l-1 
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Carbohydrate standard  
Glucose  0.1 g l-1 
Fructose  0.1 g l-1 
Sucrose  0.1 g l-1 
1-Kestose  0.1 g l-1 
1-Nystose  0.1 g l-1 
 
 
3.2.7 Metabolic labelling of cell surfaces 
 
Solution for the click reaction 
CuSO4     2 mM 
Sodium ascorbate  10 mM 
TBTA      2 mM 
in DMSO 
add 2 mM of the labelling molecule (alkynylated tetramethylrhodamine (TAMRA), 
azido- or alkynylated fluorescein). 
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3.3 Bacterial strains 
Strain Characteristics Source 
Escherichia coli 
DH10β ΔlacX74, deoR, recA1, endA1, araD139, 
Δ(ara, leu)7697, galU, galK λ- rpsL, nupG 
Gibco Life 
Technologies 
BL21(DE3) F- dcm ompT hsdS (rB- mB-) gal λ(DE3) Stratagene 
Bacillus megaterium 
DSM319 wild-type DSMZ 
Protaminobacter rubrum 
Industrial strain 
from Südzucker 
alginate-immobilised cells Südzucker 
 
3.4 Bacterial plasmids 
Plasmids Characteristics Source 
pET11d Expression vector, T7/lac-promoter, ampr  Novagen 
pRBEc1 amp
r, sacB from B. megaterium without 
signal sequence in pET11d cloned by 
BamHI and NcoI. 
Department of 
Microbiology, TU 
Braunschweig 
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3.5 Eukaryotic strains 
Strain Characteristics Source 
Aspergillus niger 
AB 1.13 
pyrG-, ampr,  Department of Microbiology, 
TU Braunschweig 
Aspergillus niger 
SKANIp8 
control, empty plasmid Department of Microbiology, 
TU Braunschweig 
Aspergillus niger 
pSKAn1015 
suc1+, pyrG-, ampr Department of Microbiology, 
TU Braunschweig 
HEp-2 human larynx carcinoma cell 
line 
Department of Microbiology, 
TU Braunschweig 
Caco-2 human epithelial colorectal 
adenocarcinoma cell line 
Department of Microbiology, 
TU Braunschweig 
CHO-K1 chinese hamster ovary cell 
line 
Rothkegel group, Department 
of Zoology, TU Braunschweig 
 
3.6 Eukaryotic plasmids 
Plasmid Characteristics Source 
ANIp8 pyrG
+, pkiA, ampr  Novagen 
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3.7 Methods 
3.7.1 Methods of molecular biology 
The basic methods of molecular biology are performed as described previously 
(Sambrook et al., 1999). The studies of the fructosyltransferase SacB from B. 
megaterium were performed in cooperation with Rebekka Biedendieck and Martin 
Gamer from the group of Dieter Jahn (TU Braunschweig, Department of 
Microbiology) and Christian Strube from the group of Dirk Heinz (Helmholtz-Centre 
for Infection research). The studies of the fructosyltransferase Suc1 from A. niger 
were performed in cooperation with Andreas Roth from the group of Petra Dersch 
(Department of Microbiology, TU Braunschweig and Helmholtz-Centre for Infection 
research). 
 
3.7.2 Heterologous protein expression of the fructosyltransferase SacB 
from B. megaterium and its variants in Escherichia coli 
BL21(DE3) 
A novel fructosyltransferase from Bacillus megaterium was identified by Rebekka 
Biedendieck from the group of Dieter Jahn (Department of Microbiology, TU 
Braunschweig). This protein shall be heterologously expressed in E. coli. For cloning 
and cultivation, E. coli cells carrying the corresponding plasmid were grown in Luria–
Bertani (LB) medium supplemented with 0.5 mM ampicillin at 37 °C in shaking flasks. 
Recombinant gene expression was induced with 0.5 mM IPTG after 3 hours and the 
temperature was lowered to 26 °C for 20 h.  
 
3.7.3 Disruption of SacB-overexpressing Escherichia coli BL21(DE3) 
cells 
The medium was centrifuged (10 min, 8000 rpm at 4 °C) and the supernatant was 
discarded. The cell pellet was dissolved in 25 ml of phosphate buffer after Sörensen 
(50mM, pH 6). After another centrifuge step at the same conditions, the pellet was 
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resuspended in 6.25 ml of Sörensen`s buffer. The cells were disrupted by sonication 
(50 % time, 70 % power) at 4 °C for 4 min.The cell extract was stored at -20 °C: 
 
3.7.4 Purification of the fructosyltransferase SacB from Bacillus 
megaterium 
The overexpressed fructosyltransferase SacB was purified by FPLC. The protein 
separation was performed by a CM-Sepharose column and monitored by a UV 
detector. The cell extract was centrifuged at 10,000 rpm for 5 min. The loading of the 
column with the crude cell extract was performed with a volume of 2.5 ml at a flow 
rate of 0.5 ml min-1. The through-flow was collected. After the loading a straight 
baseline was achieved. Subsequently the elution program was started. The elution of 
SacB was performed at a flow rate of 1 ml min-1. Fractions of 2 ml were collected. 
The elution process was monitored by the software Clarity (Ver. 2.4.1.77, Data 
Apex). The column was regenerated by the FPLC regeneration program. 
 
Table 3 FPLC program 
 
0 - 5 min                             0 % buffer Sörensen, pH 6.6, 1 M 
5 - 125 min              to      60 % buffer Sörensen, pH 6.6, 1 M 
125 - 165 min          to    100 % buffer Sörensen, pH 6.6, 1 M 
165 - 180 min                 100 % buffer Sörensen, pH 6.6, 1 M 
 
 
Table 4 FPLC regeneration program 
 
 
30 min         100% buffer Sörensen, pH 6.6, 1 M 
30 min              0% buffer Sörensen, pH 6.6, 1 M
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3.7.5 Dialysis of the purified SacB from Bacillus megaterium 
The fractions are desalted by dialysis. At high salt concentrations there is a decrease 
in protein solubility and some protein denaturing effects. Via dialysis a diffusion of the 
salt through a semi-permeable membrane occurs. The pore size of the membrane is 
crucial for the size of the molecules which are able to permeate. 
For the dialysis of the purified protein fractions, a dialysis tube (Visking Dialysis 
tubing 27/32, mass weight cut off (MWCO) 12-14,000 Da, Serva) with a variable 
volume was used. It was filled with the FPLC fractions containing pure SacB and 
dialysed at 4 °C for 1 h in 1 l of phosphate buffer after Sörensen (50 mM, pH 6.6). 
Subsequently the tube was transferred into 3 l of buffer (same composition as above) 
and dialysed over night. To support the diffusion the buffer is stirred slowly (appr. 50 
rpm). 
 
3.7.6 Protein analysis via sodiumdodecylsulfat-polyacrylamide gel 
electrophoresis (SDS-PAGE) 
By electrophoresis, proteins are seperated by their molecular weight. The proteins 
are denatured by β-mercaptoethanol and at the same time negatively charged. When 
a potential is applied they migrate through the polyacrylamide to the anode. 
The probe was mixed in a ratio of 1:4 with the loading buffer (Roth) and incubated at 
95 °C for 5 min. For the analysis commercially available gels were used (ProGel-Tris-
Glycin-Gel, 10 %, anamed) with the appropriate electrophoresis conditions. The 
staining was performed according to the coomassie staining protocol. 
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Table 5 Elektrophoresis program 
 
Collection step     80 V 30 mA 3W 15 min 
Seperation step 1   120 V 40 mA 5W 45 min 
Seperation step 2   150 V 50 mA 10W   5 min 
 
 
Table 6 Coomassie-staining protocol 
 
Fixing solution  30 min 
Staining solution  60 min 
Decolouring solution 15 min 
Decolouring solution over night 
 
 
3.7.7 Determination of protein concentrations 
The determination of the SacB concentration in the dialysed FPLC product was 
performed via spectral photometry at 280 nm (NanoDrop 3300, Thermo Scientific). 
The spectral characteristics were converted into protein concentration considering a 
correction factor for SacB. 
62,0 ccFTF           [3.1] 
 cFTF = Concentration of the fructosyltransferase SacB in solution 
 c = measured protein concentration 
1 µl of protein solution was pipetted onto the analysis device. 
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3.7.8 Determination of the activity of the purified Suc1 from Aspergillus 
niger 
The Suc1 activity after FPLC purification was determined by TLC. 500 mM sucrose 
solution in Sörensen`s buffer, 50 mM, pH 5.6, was mixed with 10 µl of each FPLC 
fraction. After 3 h, 3 µl of the reaction mixture was analysed by TLC. 
 
3.7.9 Purification of the fructosyltransferase Suc1 from Aspergillus 
niger 
The fructosyltransferase Suc1 was purified by fast protein liquid chromatography 
(FPLC) using a Sephadex 200 (Invitrogen) column. In this column material, proteins 
of high molecular weight migrate faster than small proteins. 100 µl of crude 
supernatant of an A. niger SKAn1015 cultivation was applied. The mobile phase was 
phosphate buffer after Sörensen, 50 mM, pH 5.6 without a gradient. The FPLC 
process was monitored by the software Clarity (Ver. 2.4.1.77, Data Apex). 
 
3.7.10 Deglycosylation of the purified Suc1 from Aspergillus niger 
The purified fructosyltransferase Suc1 from A. niger was deglycosylated by the action 
of the glycosidase PNGaseF (New England Biolabs). The deglycosylation process 
was performed with the native and the denatured Suc1. The denaturation of the 
enzyme was performed by heating of the purified Suc1 for 10 min at 95 °C. The 
deglycosylation procedure was performed according to the instructions of the 
manufacturer (Sigma). 
 
3.7.11 Determination of the activity of the purified deglycosylated Suc1 
from Aspergillus niger 
The Suc1 activity after the deglycosylation process was determined by TLC. 500 mM 
sucrose solution in Sörensen`s buffer, 50 mM, pH 5.6, was mixed with 10 µl of either 
the native deglycosylated or the denatured deglycosylated purified Suc1. The 
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reaction was performed at 37 °C and 200 rpm. After 3 h, 3 µl of the reaction mixture 
was analysed by TLC. 
 
3.7.12 Qualitative carbohydrate analysis via thin layer chromatography 
(TLC) 
By TLC the qualitative carbohydrate analysis was applied to get an overview of the 
enzyme activity and the resulting products. The sample to analyse was diluted to a 
total carbohydrate concentration of 1 - 3 g l-1. 3 µl of the sample was applied on a 
TLC plate (TLC aluminium foil coated with silica 60, 20 x 20 cm with concentration 
zone, Merck). After drying the TLC was run in a TLC chamber equilibrated with the 
mobile phase. After 45 min the plate was dried and again incubated for 45 min. The 
staining of the carbohydrates was performed by a short dive into the developing 
solution and incubation at 150 °C for 5 min. An appropriate standard has to be 
applied each time. 
 
3.7.13 Analysis of carbohydrates by high-performance anion-exchange 
chromatography (HPAEC) 
HPAEC analysis was used to determine the kinetic parameters of the enzyme 
reactions and the optimal reaction conditions. The HPAEC is a modular high-
performance liquid chromatography (HPLC) optimised for the analysis of 
carbohydrates. The pre-column (CarboPac PA1, 4*50 mm, Dionex) and the following 
seperation column (CarboPac PA1 4*250 mm, Dionex)) of the HPAEC device 
separate the analytes by anion-exchange and a gradient of the eluent. The samples 
were applied by an autosampler (Perkin Elmer). A degaser unit was used for 
removing oxygen and carbon dioxide from the mobile phase (sodium hydroxide, 100 
mM in MilliQ water) and the eluent (sodium hydroxide, 100 mM and sodium acetate, 
1 M in MilliQ water). A thermostat ensured a stable temperature of 15 °C. The flow 
rate was 1 ml min-1. The total carbohydrate concentration has to be set to 100 – 200 
mg l-1 correlating with the used detector sensitivity of “1k”. The chromatograms were 
recorded with the Clarity software (Ver. 2.4.1.77, DataApex). 
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Table 7 HPAEC program 
 
  0 - 5 min  0 % NaOH, NaAc 
  5 - 25 min    to   25 % NaOH, NaAc 
25 - 30 min    to   50 % NaOH, NaAc 
30 - 35 min          50 % NaOH, NaAc 
35 - 37 min      to   0 % NaOH, NaAc 
37 - 60 min            0 % NaOH, NaAc 
 
 
3.7.14 Nuclear magnetic resonance (NMR)-spectroscopy analysis of 
carbohydrates 
All samples to be analysed by NMR were freeze-dried and dissolved in D2O (or 900 
mM NaOD when indicated). Spectra were recorded on a Bruker DRX600 or Bruker 
DRX400 operating at 600 and 400 MHz, respectively. One-dimensional 1H and 13C 
spectra and phase-sensitive two-dimensional spectra (double-quantum-filtered 
COSY, NOESY (Nuclear overhauser and exchange spectroscopy), TOCSY (Total 
correlated spectroscopy), 1H-13C HSQC (Heteronuclear single quantum coherence) 
and HMBC (Heteronuclear multiple bond correlation)) were recorded using standard 
pulse programs at 38.8 °C, and data were analysed using the software packages 
XWINNMR (Bruker, Germany). Chemical shifts are calculated in the -scale (ppm) 
and coupling constants J in Hz. 
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3.7.15 Biochemical characterisation of the wild-type 
fructosyltransferase SacB from Bacillus megaterium 
3.7.15.1 Determination of the optimal enzyme and substrate 
concentration 
The optimal enzyme concentration was determined in 50 mM Sörensen’s phosphate 
buffer (pH 6.6) at 37 °C and 500 mM sucrose. The tested enzyme concentrations 
were 73.60, 29.44, 14.72, 7.36, and 4.91 mg l-1 purified SacB, respectively. 
Reactions were stopped after 1 h by heating (100 °C, 10 min). The release of 
fructose and glucose from sucrose was analysed by TLC and HPAEC. The optimal 
substrate concentration for the transfructosylation was determined in 50 mM 
Sörensen’s phosphate buffer (pH 6.6) at 37 °C at 7.36 mg l-1 purified SacB 
concentration. Sucrose concentrations tested were 1 M, 750, 500, and 250 mM, 
respectively. Reactions were stopped after 1 h by heating (100 °C, 10 min) and 
analysed as described above. The optimal reaction conditions for the wild-type and 
the variants were at an enzyme concentration of 7.36 mg l-1, a substrate 
concentration of 500 mM sucrose, and a reaction time of 60 min. The release of 
glucose was measured by HPAEC. 
 
3.7.15.2 Determination of the pH optimum 
The influence of the pH on the fructosyltransferase reaction was investigated. The 
phosphate buffer was adjusted to six different pH values between 5 and 8 (table 10). 
The substrate concentration was 500 mM and the enzyme concentration was 7.36 
mg l-1. The mixture was shaken at 200 rpm and 37 °C for 1 h. Samples were taken 
after 2, 10 15, 30 and 60 min. The enzyme in the samples was inactivated by heating 
(100 °C, 10 min). The samples were analysed by TLC and HPAEC. 
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Table 8 Buffer after Sörensen, 50 mM, pH 5-8 
 pH 5.0 pH 5.6 pH 6.0 pH 6.6 pH 7.0 pH 7.6 pH 8.0 
KH2PO4 (% v/v) 99.2 95.5 88.9 65.3 41.3 12.8   3.7 
Na2HPO4 (% v/v)   0.8   4.5 11.1 34.7 58.7 87.2 96.3 
 
 
3.7.15.3 Determination of the temperature optimum 
According to the Arrhenius function a small rise in temperature in the area of the 
temperature maximum leads to a fast inactivation of the enzyme. To avoid these 
denaturing effects the experiments were performed some degrees below the 
maximum activity of the enzyme. The determination of the temperature optimum was 
performed in Sörensen`s phosphate buffer at pH 6.6. The substrate concentration of 
sucrose was 500 mM. The concentration of the fructosyltransferase SacB was 7.36 
mg l-1. The mixtures were incubated at different temperatures (25, 30, 37, 40, and 50 
°C) at 200 rpm. Samples were taken after 1, 6, 15, 30, 45 and 60 min. The enzyme 
was inactivated by heating for 10 min at 100 °C. The samples were analysed by TLC 
and HPAEC. 
 
3.7.16 Determination of the kinetic parameters of the 
fructosyltransferase SacB from Bacillus megaterium and its 
variants 
The kinetic parameters Km and kcat describe the architecture of the active site 
concerning substrate binding and turnover. The substrate affinity, reaction rate and 
catalytic efficiency are essential characteristics of an enzyme. 
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3.7.16.1 Determination of the specific activity 
The wild-type fructosyltransferase SacB from B. megaterium in a concentration of 
7.36 mg l-1 was mixed with a sucrose solution (500 mM) in phosphate buffer (50 mM, 
pH 6.6) and incubated at 37 °C. Samples were taken during one hour reaction time 
(after 30 sec, 1, 1.5, 2, 2.5, 3, 3.5, 10, 22, 30, 45 and 60 min). The samples were 
analysed by HPAEC. 
The specific activity of an enzyme results from the slope of the tangent to the linear 
area of the saturation hyperbola. A regression was performed using the equation of 
Michaelis-Menten (equation [1.3]). The activity was determined by a regression to the 
linear area of the hyperbola (until 10 min reaction time). 
 
3.7.16.2 Determination of the kinetic parameters after Michaelis-Menten 
To determine the kinetic parameters Km and kcat of the fructosyltransferase SacB 
from B. megaterium, the purified enzyme was used in an end concentration of 7.36 
mg l-1 at a pH of 6.6 and 37 °C. Substrate concentrations of 500 to 1 mM were used 
(500, 250, 100, 50, 25, 10, 5, 2.5 and 1 mM). The dilutions were made from a 1 M 
sucrose stock solution containing SacB so the enzyme was diluted proportionally. 
After 1 h the reaction was stopped by heating for 10 min at 100 °C. The samples 
were analysed by HPAEC. 
The specific product formation velocity (v/U) was plotted with the substrate 
concentration (S). The Km and vmax values were determined by a regression with the 
Michaelis-Menten function [1.3]. The determination of kcat was performed according 
to equation 1.4. The catalytic efficiency results from the equation 1.6. 
 
3.7.17 Analysis of the product spectrum of the wild-type 
fructosyltransferase SacB from Bacillus megaterium and its 
variants 
The product spectrum of the wild-type fructosyltransferase and the mutants shall be 
determined to prove the postulated function of the exchanged amino acids. First, a 
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kinetic was performed with the wild-type enzyme under optimised reaction conditions 
(50 mM Sorenson’s phosphate buffer, pH 6.6 and 500 mM sucrose at 37 °C) in order 
to get an overview of the reaction time and the wild-type product spectrum. The 
enzyme concentration was 100 mg l-1 to get a full conversion of sucrose. The 
sampling time points were 30 sec, 30 min, 60 min, 24 h and 72 h. The samples were 
analysed by TLC and HPAEC using standards (1-kestose, 6-kestose, 1-nystose). For 
the qualitative determination of the product spectra of the variants the incubation was 
performed under optimised reaction conditions for 72 h to ensure a complete 
conversion of sucrose regarding the wild-type. The product spectra of the variants 
were also analysed by TLC. All unidentified oligosaccharides were separated by 
silica gel column chromatography (3.5 x 500 mm, flow rate 500 µl min-1) and 
analysed by NMR and mass spectroscopy. 
 
Table 9 HPAEC protocol for mono- and disaccharide analysis 
t [min] % eluent 
0-5 0 
5-30 0-50 
30-35 50 
35-40 to 0 
40-60 0 
 
 
3.7.17.1 Characterisation of precipitated oligo- and polysaccharides 
synthesised by the fructosyltransferase SacB from Bacilus 
megaterium 
The formation kinetic of the polysaccharide was examined in 50 mM Sorenson’s 
phosphate buffer (pH 6.6) at 37 °C, 500 mM sucrose and 7.36 mg l-1 enzyme 
concentration. Samples were taken after 30 sec, 30 min, 60 min, 24 h, and 72 h, 
respectively, and analysed by TLC. The production of the polysaccharide was 
performed in Sorensen’s phosphate buffer (50 mM, pH 6.6) at 37 °C with 100 mg l-1 
SacB. After 10 min the polymer was precipitated with 1 volume of ethanol (99 % 
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(v/v)). After centrifugation (14,000 x g, 5 min, 4 °C) the supernatant was discarded 
and the precipitate was freeze-dried.  
For the identification of the linkage type, the polysaccharides were produced as 
described above and dialysed with water at 4 °C over night (Slide-A-Lyzer Dialysis 
cassettes, Pierce, MWCO 30 kDa). The sample was centrifuged for 5 min at 14,000 g 
and the supernatant was discarded. The precipitate was washed four times with 1 ml 
of ethanol dissolved in water (66 % (v/v)). The polysaccharides were freeze-dried and 
dissolved in 900 mM NaOD for NMR spectroscopy. 
 
Table 10 HPAEC protocol for oligosaccharide analysis 
t [min] % eluent 
0-5 0 
5-10 0-30 
10-40 30 
40-45 30-0 
45-60 0 
 
 
3.7.18 Synthesis of novel fructo-oligosaccharides by the concerted 
action of two fructosyltransferases from Bacillus megaterium 
and Aspergillus niger 
3.7.18.1 Synthesis of sucrose analogues by the fructosyltransferase 
SacB from Bacillus megaterium 
The fructo-oligosaccharides were synthesised in two steps. First, sucrose analogues 
were synthesised by the fructosyltransferase SacB from B. megaterium as described 
previously (Seibel et al., 2006b). Briefly, the acceptor carbohydrate was used in a 
concentration of 1.2 M and sucrose in a concentration of 600 mM dissolved in 
phosphate buffer after Sörensen (50 mM, pH 6.6). SacB was applied in a final 
concentration of 10 mg l-1. The reaction was performed at 200 rpm and 37 °C for 2 h. 
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The purification of the sucrose analogues was performed by a silica column with the 
mobile phase analogous to the TLC analysis of carbohydrates (60 % ethylacetate, 30 
% isopropanol, 10 % water, all v/v). The products were analysed by TLC (Merck), 
HPAEC (Dionex) and 1D and 2D 1H and 13C NMR (Bruker).  
 
3.7.18.2 Synthesis of 1-kestose and 1-nystose and their analogues by 
the fructosyltransferase Suc1 from Aspergillus niger 
The subsequent synthesis step of 1-kestose and 1-nystose and their analogues was 
performed by the fructosyltransferase Suc1 from A. niger. The supernatant of a 
cultivation of A. niger SKAN1015 was used in a dilution of 1:50 (v/v). The Suc1 
dilution was mixed with 500 mM of the sucrose analogue to be converted in 
Sörensen`s phosphate buffer (50 mM, pH 5.6). The reaction was performed at 45 °C 
and 200 rpm. The reaction time depends on the desired oligosaccharide to be 
synthesised (table 13). 
 
Table 11 Reaction times and yields for the synthesis of novel fructo-
oligosaccharides by the fructosyltransferase Suc1 from A. niger. 
 t [min] Conversion [%] 
1-kestose (Glc-Fru2) 
1-nystose (Glc-Fru3) 
18 
60 
81 
93 
Man-Fru2 
Man-Fru3 
60 
180 
71 
87 
Gal-Fru2 
Gal-Fru3 
420 
960 
44 
65 
Xyl-Fru2 
Xyl-Fru3 
20 
120 
75 
94 
Fuc-Fru2 
Fuc-Fru3 
60 
120 
65 
88 
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3.7.19 Growth screen of beneficial gut bacteria (probiotics) with 
different carbohydrate sources (prebiotics) 
The growth screen of the Lactobacilli and Bifidobacteria was performed in 
cooperation with Andreas Roth from the group of Petra Dersch (Department of 
Microbiology, TU Braunschweig and Helmholtz-Centre for Infection Research). 
Four different strains of Lactobacilli (Lb. fructosus, Lb. plantarum, Lb. fermentum, Lb. 
delbrueckii, Department of Microbiology) and Bifidobacterium lactis (DSMZ) were 
investigated regarding their potential growth on 1-kestose and 1-nystose. 
Oligofructosides are considered to act as prebiotics promoting the growth of 
beneficial gut bacteria. 
The Lactobacilli were first cultivated at 37 °C in a full medium (MRS) over night. As 
microaerophiles they grow on the bottom of culture tubes. The Bifidobacteria were 
grown under anaerobic conditions in culture tubes containing MRS-medium 
overlayed with glycerin at 37 °C for 2 d. 
The Lactobacilli and Bifidobacteria were screened for their ability to grow on 1-
kestose and 1-nystose. Each strain was fed with glucose as a control, 1-kestose and 
1-nystose in concentrations of 500 and 200 mM (glucose) or 100 and 75 mM (1-
kestose and 1-nystose), respectively. A 96-well plate was prepared with MRS full 
medium or semi-defined medium (200 µl each) with glucose, 1-kestose and 1-
nystose or no carbohydrates as negative control (table 14) (Korakli et al., 2003). For 
the growth of the strictly anaerobic Bifidobacteria the well was overlayed with 
glycerin. The inoculation was performed with a culture of Lactobacilli or Bifidobacteria 
in MRS medium in the exponential growth phase with 1/10 volume. The 96-well plate 
was incubated at 37 °C and the OD580 was measured after 1, 24, 28 and 40 hours.  
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Table 12 Semi-defined medium for Lactobacilli and Bifidobacteria growth screen 
after Vogel (Korakli et al., 2003). 
Compound c [g L-1] 
NH4Cl 2 
Na acetate 5 
MnSO4 0,05 
K2HPO4 2 
Yeast Nitrogen Base (Difco) 5 
Bacto Pepton (Difco) 10 
Glucose (500 mM, 200 mM), 1-kestose (150 mM, 75 mM) or 1-nystose (150 mM, 75 
mM) were added as carbon source. 
 
3.7.20 Cultivation of eukaryotic cells 
3.7.20.1 Cultivation of HEp-2 cells 
The cells were cultivated in 20 ml RPMI (“Roswell Park Memorial Insitute”) medium 
containing 7.5 % newborn calf serum (NCS) at 37 °C in 5 % CO2 atmosphere. At    
80 % confluence (appr. 2-3 days) the medium was discarded and the cells were 
washed with PBS buffer (Gibco). By application of 1.5 ml of trypsin/EDTA mixture the 
cells were detached for 5 min at 37 °C. They were supplied with 8.5 ml of fresh 
medium and split in a ratio of 1:10. 
 
3.7.20.2 Cultivation of Caco-2 cells 
The cells were cultivated in 20 ml Dulbecco`s modified Eagle`s medium 
supplemented with HamsF12 nutrient (DMEM / HamsF12, ratio 1:1) containing 10 % 
fetal calf serum (FCS) at 37 °C and 5 % CO2. At 80 % confluence (appr. 2-3 days) 
the medium was discarded and the cells were washed with PBS buffer (Gibco). By 
applying 1.5 ml of trypsin/ethylene diamine tetra acetate (EDTA) mixture the cells 
were detached for 5 min at 37 °C. They were supplied with 8.5 ml of fresh medium 
and split in a ratio of 1:10. 
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3.7.20.3 Cultivation of CHO-K1 cells 
The cells were cultivated in 20 ml DMEM / HamsF12 (1:1) containing 10 % FCS at 37 
°C and 5 % CO2 atmosphere. At 80 % confluence the medium was discarded and the 
cells were washed with PBS buffer (Gibco). By the application of 1.5 ml of 
trypsin/EDTA mixture the cells were detached for 5 min at 37 °C. They were supplied 
with 8.5 ml of fresh medium and split in a ratio of 1:10. 
 
3.7.21 Cytokine assay of Caco-2 cells 
For the fructo-oligosaccharide assay, Caco-2 cells at 80 % confluence were split as 
described and cultivated in 24-well dishes (Biochrom). Each well was supplied with 
the oligofructoside to be tested in a concentration of 25 µM. After 48 h (80 % 
confluence) the supernatant medium was collected for cytokine analysis. 
The assay was performed with a 25-plex human cytokine analysis kit according to the 
manufacturer`s instructions (Biosource, Invitrogen). Briefly, the supernatant medium 
was incubated with antibody-functionalised beads and detected with biotinylated 
secondary antibodies. Streptavidin-R-phycoerythrin (RPE) was used as fluorescence 
marker. The final analysis was performed by the luminex system (Qiagen) which 
recognises spectral properties of the beads and quantifies the bead load by the 
specific fluorescence intensity (figure 28). In the 96-well plate provided, we analysed 
15 different oligosaccharides (sucrose, palatinose, 1-kestose, 1-nystose, Gal-Fru, 
Gal-Fru2, Man-Fru. Man-Fru2, Man-Fru3, Fuc-Fru, Fuc-Fru2, Fuc-Fru3, Xyl-Fru, Xyl-
Fru2 and Xyl-Fru3). The concentrations of 25 different cytokines and chemokines 
were analysed in each sample (Eotaxin, granulocyte macrophage colony stimulating 
factor (GM-CSF), Interferon (IFN)-α, IFN-γ, interleukin (IL)-1RA, IL- 1β, IL-2, IL-2R, 
IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12p40/p70, IL-13, IL-15, IL-17, IP-10, monocyte 
chemotactic protein (MCP)-1, monokine induced by gamma interferon (MIG), 
macrophage inflammatory protein (MIP)-1α, MIP-1β, regulated upon activation, 
normal T-cell expressed and secreted (RANTES) and tumour necrosis factor (TNF)-
α). 
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Figure 28 The analysis principle of the 25-plex human cytokine analysis kit 
(Biosource). 
 
3.7.22 Metabolic labelling and modification of cell surfaces 
HEp-2, CHO and CHOlec 3.2.8.1 cells were cultivated as described previously. For 
labelling experiments they were split at 80 % confluence into 6-well dishes and 
incubated in 2 ml of media suited for the individual cell line. The medium contained 
25 µM of the modified carbohydrate to be incorporated (AcGlcNAz, GlcNAz, NeuNAz 
or NeuNHex). The incubation time was two days until 80 % confluence. The cells 
were detached using a cell scraper. 150 µl of each well were transferred into an 8-
well microscopy cultivation slide and filled with 150 µl of the fresh medium 
appropriate for the cultivated cell line. The cells were cultivated at the described 
growth conditions until reattachment (control by microscopy). The medium was 
discarded and the cells were washed several times with PBS buffer (Gibco). The 
labelling reaction was performed in the dark with 2 mM of the desired labelling 
molecule (alkynylated tetramethylrhodamin (TAMRA), azido- or alkynylated 
fluorescein) with 2 mM CuSO4, 10 mM sodium ascorbate and 2 mM Tris-[(1-benzyl-1-
H-1,2,3-triazol-4-yl) methyl]amine (TBTA) in dimethylsulfoxide (DMSO). After 1 h 
each well was washed several times with DMSO/water (1:1) and subsequently 
examined by fluorescence microscopy.  
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3.7.23 In silico tools for carbohydrate and protein studies 
Computers are getting more and more powerful concerning their calculation time for 
challenging simulation scenarios. The field of biology with many macromolecules like 
proteins, RNA and DNA and an overwhelmingly number of metabolic processes is a 
big challenge for computational approaches. In this chapter, some versatile software 
tools and web resources are introduced (tables 13 and 14). 
The interactions of enzymes with a ligand can be simulated with Autodock 
(http://autodock.scripps.edu, Scripps Institute, LaJolla, CA, USA). The structure of the 
protein and the ligand has to be available in pdb, Mol2, MEAD, Gromacs or MMCIF 
format. The crucial problem is to find a balance between the computational effort and 
reasonable results. In Autodock it was realised by a grid-based energy evaluation 
and an efficient search for torsional freedom of the amino acid residues as well as the 
substrate to be docked. However, the limited flexibility of especially the protein is a 
drawback of this method. 
The calculation of protein structures lacking a pdb entry was performed by 
ESyPred3d (http://www.fundp.ac.be/sciences/biologie/urbm/bioinfo/esypred). The 
software screens the RCSB pdb database (http://www.rcsb.org/pdb) for similar 
proteins and calculates the structure based on several multiple alignment programs. 
The resulting pdb file is created by the software MODELLER (Lambert et al., 2002). 
The prediction of potentially glycosylated arginine residues and in silico glycosylation 
of proteins is performed by GlyProt (Zentrale Spektroskopie, Molecular Modeling, 
Deutsches Krebsforschungszentrum, DKFZ, Heidelberg). It processes existing pdb 
files from the RCSB pdb database and accepts uploaded pdb files. The software 
predicts possible N-glycosylation sites based on a score function which includes 
accessibility and torsion angles of arginine candidates for glycosylation. The 
oligosaccharides to be attached can be selected from a list or defined manually. 
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Table 13 Software tools for protein and glycosylation analysis used in this thesis. 
Tool Description URL 
Autodock Simulation of protein-
ligand interactions 
http://autodock.scripps.edu 
GlyProt In silico glycosylation of 
proteins 
http://www.glycosciences.de/mode
ling/glyprot/php/main.php 
ESyPred3D Calculation of protein 
structures based on 
amino acid sequences 
http://www.fundp.ac.be/sciences/bi
ologie/urbm/bioinfo/esypred 
GlycoWorkBench Drawing of simplified 
glycan structures, MS 
fragmentation 
http://www.ebi.ac.uk/eurocarb/gwb
/home.action 
DALI Structural alignment of 
proteins 
http://www.ebi.ac.uk/Tools/dalilite 
Pymol 3D protein structure 
analysis 
http://pymol.org/ 
NetNGlyc Prediction of protein 
glycosylation sites 
http://www.cbs.dtu.dk/services/Net
NGlyc 
 
 
Table 14 Databases for protein and carbohydrate analysis used in this thesis. 
Database Description URL 
RCSB pdb Protein 3D structures http://www.rcsb.org/pdb 
BRENDA Protein characteristics http://www.brenda-enzymes.org 
PubMed Medical and biochemical 
literature  
http://www.pubmed.gov 
CFG Glycan profiles of animal 
cells 
http://www.functionalglycomics.org/glyc
omics/publicdata/glycoprofiling.jsp 
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4 Results and Discussion 
4.1 Oligo- versus polysaccharide synthesis – Controlling 
the action of glycosyltransferases by enzyme 
engineering 
The studies of the fructosyltransferase SacB from B. megaterium were performed in 
cooperation with Rebekka Biedendieck and Martin Gamer from the group of Dieter 
Jahn (TU Braunschweig, Department of Microbiology) and Christian Strube from the 
group of Dirk Heinz (Helmholtz-Centre for Infection Research) 
 
4.1.1 Identification, cloning, expression and purification of the novel 
fructosyltransferase SacB from Bacillus. megaterium 
When B. megaterium was cultivated in Luria-Bertani (LB)-medium supplemented with 
and without 0.5 % (w/v) sucrose, SDS-PAGE comparison of the secretome from both 
cultivations revealed a dominant protein solely produced in the presence of sucrose. 
This protein with a relative molecular mass of 52 kDa was identified by Rebekka 
Biedendieck from the group of Dieter Jahn (Department of Microbiology, TU 
Braunschweig). The analysed peptide fragments were homologous to fragments 
predicted for the levansucrase SacB, a 473 amino acid residue exo-enzyme of B. 
subtilis. BLAST searches of the B. subtilis SacB against the translated genome data 
of B. megaterium led to the identification of the SacB protein sequence and the 
genomic position of the corresponding sacB gene (Kunst et al., 1997; Biedendieck, 
2006; Sun. et al., 2006; Homann et al., 2007). B. megaterium SacB consists of 484 
amino acids including the 29 amino acids of an N-terminal signal peptide. It shows 74 
% identity at the amino acid sequence level to SacB from B. subtilis. Hence, the B. 
megaterium protein was also named SacB. Nine of the 11 additional amino acids 
found in B. megaterium SacB compared to SacB of B. subtilis are adjacent to one 
another at location 82–90 (B. megaterium SacB numbering). Like sacB of B. subtilis, 
sacB of B. megaterium is the first gene of an operon. It is followed by a gene 
consisting of 1,563 bp. The deduced protein sequence shows 66 % identity to the 
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levanase LevB from B. subtilis. B. subtilis levB is also the second gene in an operon 
(Sun. et al., 2006). The third and last gene in the operon in B. subtilis encodes a 520 
amino acid protein which might function as a permease (Sun. et al., 2006). 
Interestingly, the protein encoded by a gene sequence following the levanase gene 
sacB in B. megaterium was annotated as bacterioferritin (Hundertmark, Hiller, 
Münch, Jahn, 2005; unpublished data). SacB from B. megaterium was 
heterologously expressed in E. coli and purified by FPLC (figures 29 and 30). 
 
 
Figure 29 FPLC-purification of the wild-type fructosyltransferase SacB from B. 
megaterium. SacB was seperated by ion-exchange chromatography and eluted with 
1 M Sörensen`s buffer, pH6.6. 
 
 
Figure 30 SDS-PAGE analysis of the FPLC fractions (figure 29). Lane 1 is the 
crude cell extract, 2 is the flow-through of the FPLC, 3 is the first FPLC peak fraction 
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(fraction 21, figure 29), 4 is the protein marker (New England Biolabs, relative 
molecular masses are indicated in kDa), lanes 5 to10 are the FPLC peak fractions 
(22-27, figure 29). The apparently pure SacB-containing fractions are boxed. 
 
The pH optimum of the fructosyltransferase SacB from B. megaterium is pH 6.6 and 
the temperature optimum is 45 °C (figures 31 and 32, table 15). The linear area of 
the Michaelis-Menten plot was determined to be in between 10 min under the given 
reaction conditions (pH 6.6, 37 °C, 7.36 mg l-1 enzyme, 500 mM sucrose; figure 33). 
 
 
Figure 31 The pH-optimum of the wild-type fructosyltransferase SacB from B. 
megaterium. Reaction parameters were 37 °C, 500 mM sucrose, 7.36 mg l-1 purified 
SacB in 50 mM Sörensen phosphate buffer at pH values between 5 and 8. The 
reaction was stopped after 1 h by denaturation (100 °C, 10 min). 
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Figure 32 The temperature-optimum of the wild-type fructosyltransferase SacB 
from B. megaterium. Reaction parameters were pH 6.6, 500 mM sucrose, 7.36 mg l-1 
purified enzyme in 50 mM Sörensen`s phosphate buffer between 30 and 50 °C. The 
reaction was stopped after 1 h by enzyme denaturation (100 °C, 10 min). 
 
 
Figure 33 Determination of the linear plot region according to Michaelis-Menten of 
the wild-type fructosyltransferase SacB from B. megaterium. Reaction parameters 
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were 37 °C, 500 mM sucrose, 7.36 mg l-1 purified enzyme in 50 mM Sörensen`s 
phosphate buffer at pH 6.6. Samples were taken after 30 sec, 1, 1.5, 2, 2.5, 3, 3.5, 
and 10 min. The reaction was stopped by denaturation (100 °C, 10 min). 
 
Table 15 The optimal reaction conditions for the fructosyltransferase SacB from 
B. megaterium are shown in comparison to the fructosyltransferase from B. subtilis. 
 
SacB from 
B. subtilis (BRENDA) 
SacB from 
B. megaterium  
Km 13.5 – 40 mM 6.6 mM 
TO number (kcat) 0.6 – 165 s
-1 2272 s-1 
pH optimum pH 6 for hydrolysis pH 6.6 for hydrolysis 
T optimum 37 – 50 °C 45 °C 
stability  
pH 3.5 to 7.5 at 4 °C, no 
time indicated 
> 6 months at pH 6.6 and -20 °C 
 
 
4.1.2 Kinetic studies and characterisation of the product spectrum of 
the wild-type fructosyltransferase SacB from Bacillus megaterium 
The kinetic parameters were determined as described in materials and methods 
(3.7.16). The Km value of 6.6 mM for hydrolysis measured for the wild-type SacB from 
B. megaterium is low compared to other levansucrases, e.g. SacB from B. subtilis 
with 13.5 to 40 mM according to BRENDA database (Schomburg et al., 2002). This 
indicates a high affinity to the substrate sucrose supported by a very high kcat     
(2272 s-1) and a high catalytic efficiency (346 mM-1 s-1; table 14). The reaction 
conditions used for the determination of the product spectrum favour hydrolysis (58.4 
%) followed by synthesis of polyfructan (22.1 %). Further analysis showed that 
polyfructan synthesised by SacB from B. megaterium had a molecular weight of 
2,711 kDa and consists of mainly β-(2,6) linkages. The polyfructan produced by SacB 
from B. subtilis had a Mw of 6,295 kDa and was described as β-(2,6)-linked levan with 
some β-(2,1) branches (Chambert et al., 1974). Besides the polyfructan formation, 
the wild-type SacB of B. megaterium also synthesises five different detectable 
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oligosaccharides. Three products were identified by HPAEC as 1-kestose, 6-kestose, 
and 6-nystose which are known acceptors for the transfer of fructosyl units (van 
Hijum et al., 2006; figure 37).  
The two unknown by-products were isolated and analysed by 1- and 2D-NMR and 
mass spectroscopy (figures 34 and 35, tables 16 and 17). The 1-D proton spectrum 
of the first compound showed two anomeric protons (4.6-5.2 ppm) which correspond 
to an anomeric mixture of two non-reducing sugar residues. The 1-H signal the -
configurated glucoside-residue resonated at higher field (4.59 ppm) with a large 
coupling constant (d, 7.96Hz) where the 1-H signal (5.16 ppm) of the -configured 
glucose appeared as minor signal of a reducing sugar in a ratio of : 1:2. Based on 
the results of the 2-D COSY spectrum, correlations were observed between the H-1`s 
of the glucose residues and the corresponding H-2`s (alpha 3.8-4.1 ppm; beta 3.20-
3.16 ppm), which was coupled to H-3`s (alpha 3.63-3.68 ppm; beta 3.42-3.40 ppm). 
The assignments for the anomeric carbon signals (alpha 94.94 ppm; beta 98.79 ppm) 
and C-2s (alpha 74.27 ppm, beta 76.89 ppm) were achieved by 2-D HSQC spectrum 
analysis. In addition, 1H 13C HMBC long range 2J and 3J correlations were observed 
for the H-6 signal of glucose with the 13C signals at δC 106.52 ppm (alpha, C-2’) and 
106.55 ppm (beta, C-2’) of the fructofuranoside, respectively, which shows 
correlations for the fructofuranoside H-3’ positions (beta 79.78 ppm; alpha 79.68 
ppm/4.58 ppm) and H-4’ positions (beta 77.45 ppm; alpha 77.31 ppm/4.07 ppm) 
(figure ???). All other carbon and proton signals were assigned from a combination of 
2-D COSY, TOCSY, HMBC, and HSQC experiments. All experiments provide strong 
evidence of an 1:2 :β mixture of β-(2,6)-Fru-α,β-Glc ((2,6)-O-β-D-fructofuranosyl-
α,β-D-glucopyranoside, blastose). 
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Figure 34 Unidirectional formation of blastose from neokestose as the 
accumulating product by the fructosyltransferase SacB from B. megaterium.  
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Figure 35 2D-NMR correlation spectrum of α, blastose (HMBC)  
 
 
 
77 
Table 16 13C NMR data for the identification of blastose. 
 -blastose β-blastose 
C-atom C  H C  H 
C-1 
C-2 
C-3 
C-4 
C-5 
C-6 
94.94 
74.27 
75.48 
72.55 
73.49 
63.61 
5.16 (d, 3.70) 
3.49-3.46 (m) 
3.63-3.68 (m) 
3.34-3.40 (m) 
3.85-3.88 (m) 
3.96-3.89, 3.67-3.62 
98.79 
76.89 
78.45 
72.49 
77.79 
63.61 
4.59-4.57 (d, 7.96) 
3.20-3.16 (t, 8.70) 
4.42-3.40 (m) 
3.88-3.85 (m) 
3.84-3.80 (m) 
3.96-3.89, 3.67-
3.62 
C-1’ 
C-2’ 
C-3’ 
C-4’ 
C-5’ 
C-6’ 
62.99 
106.52 
79.68 
77.31 
83.97 
65.21 
3.70-3.62 (m) 
- 
4.58-4.56 (d, 8.26) 
4.07-4.03 (t, 7.60) 
3.82-3.76 (m) 
3.77-3.72 (m) 
62.99 
106.55 
79.78 
77.45 
84.02 
65.32 
3.70-3.62 (m) 
- 
4.58-4.56 (d, 8.26) 
4.07-4.03 (t, 7.60) 
3.82-3.76 (m) 
3.77-3.72 (m) 
 
Table 17 13C NMR data for the identification of neokestose. 
 neokestose 
C-atom C  H 
C-1 
C-2 
C-3 
C-4 
C-5 
C-6 
62.89 
106.45 
79.47 
77.03 
83.88 
65.17 
3.91-3.87, 3.76-3.73 
- 
4.16-4.13 (d, 8.5) 
4.11-4.07 (t, 7.4) 
3.84-3.80 (m) 
3.83-3.73 
C-1’ 
C-2’ 
C-3’ 
C-4’ 
C-5’ 
C-6’ 
94.74 
73.74 
75.15 
74.76 
71.89 
62.03 
5.35 (d, 3.88) 
3.53-3.49 (dd, 3.90, 10.00) 
3.69-3.66 (m) 
3.92-3.88 (m) 
3.48-3.45 (m) 
3.58 (s) 
C-1’’ 
C-2’’ 
C-3’’ 
C-4’’ 
64.14 
106.47 
78.90 
76.64 
3.73-3.69, 3.64-3.61 
- 
4.18-4.16 (d, 8.49) 
4.04-4.00 (t, 8.5) 
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C-5’’ 
C-6’’ 
84.08 
65.08 
3.87-3.83 (m) 
3.80-3.76, 3.68-3.64 
 
The electro-spray ionisation mass spectrum (ESI/MS) of the second compound 
showed the molecule peak at m/z = 527 [M+Na+]. This trisaccharide is a non reducing 
oligosaccharide. In the 1-D proton spectrum the anomeric proton resonated at δH 
5.35 ppm with a small J12 value of 3.90 Hz. This proton showed correlation in the 2D-
HMBC spectrum with quaternary carbon C-2’ (106.45 ppm) of a fructofuranoside 
residue. In the 2-D HMBC spectrum protons corresponding of the H-6 glucose 
residue showed correlations to the quaternary carbons C-2’’ of a second 
fructofuranoside residue. Taken together, all signals assigned from the one 
dimensional and correlation spectroscopy (i.e. COSY, TOCSY, HMBC, DEPT and 
HSQC), the trisaccharide was identified as β-(2,6)-Fru-α-Glc-β-(1,2)-Fru ((2,6)-O-β-D-
fructofuranosyl-α-D-glucopyranosyl-(1,2)-O-β-D-fructofuranoside, neokestose). 
 
 
Figure 36 TLC analysis of the reaction product pattern of the wild-type 
fructosyltransferase SacB from B. megaterium at 7.36 mg l-1 enzyme, 0.5 M sucrose, 
pH 6.6, 37 °C. The sample times are indicated in minutes when not stated otherwise. 
Sacch. is sucrose, OS is oligosaccharides and PS is polysaccharide. 
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Figure 37 Identification of the transfructosylation products. The carbohydrates up 
to tetrasaccharides were identified by high-performance anion-exchange 
chromatography (HPAEC). The dotted line is the oligosaccharide standard (1-
kestose, 6-kestose, nystose, all 0.01 g l-1), the solid line is the wild-type SacB 
reaction (stopped after 19 h at 37 °C and 0.5 M sucrose in Sorensen`s phosphate 
buffer, 50 mM, pH 6.6, enzyme concentration was 0.1 g l-1), the dashed line is the 
oligosaccharide standard (concentration as above) mixed with the same wild-type 
SacB sample. 
 
4.2 Crystallisation of the fructosyltransferase SacB from 
Bacillus megaterium 
The crystallisation and the structural refinement of the fructosyltransferase SacB from 
B. megaterium was performed by Christian Strube from the group of Dirk Heinz at the 
Helmholtz-Centre for Infection Research. The 3D structure (1.6 Å) shows essentially 
the same five-fold β-propeller motif as the SacB from B. subtilis. The active site 
contains the catalytic triad D95/D257/E352 with E352 acting as the acid/base catalyst 
and D95 as the nucleophile. The amino acid residue N252 is located in the +2-site 
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(figures 38 and 39). The interactions of the amino acids located in the active site with 
sucrose (figure 40) can be clearly identified as the analogous to SacB from Bacillus 
subtilis cocrystallised with sucrose. 
 
 
Figure 38 Crystal structure of the D257A variant of SacB from B. megaterium with 
sucrose modelled into the active site in a resolution of 1.6 Å. The catalytic triad is 
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shown in grey balls and red label. Asn252 in subsite +2 is shown as a yellow ball and 
green label. The structure refinement was performed by Christian Strube in the group 
of Dirk Heinz (Helmholtz-Centre for Infection Research). 
 
 
Figure 39 The active-site architecture of the fructosyltransferase SacB from B. 
megaterium with modelled sucrose. 
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Figure 40 The interactions of the amino acids located in the active site of the 
fructosyltransferase SacB from B. megaterium variant D257A with the natural 
substrate sucrose (black). N252 which is not located in the active site is supposed to 
stabilise the third fructosyl unit for the transfructosylation process (indicated in green). 
The position of D257 was modelled by pymol (DeLano Scientific). The distances are 
given in Å. 
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4.3 Mutagenesis studies of the fructosyltransferase SacB 
from B. megaterium 
4.3.1 Identification of amino acid residues located in the active site with 
impact on the enzyme activity and the transfructosylation reaction 
By sequence alignments of the fructosyltransferase from B. megaterium with the 
levansucrase from B. subtilis and various other fructosyltransferases, we identified 11 
amino acids in the active site (figure 41). The identified amino acid residues were 
exchanged to alanine in order to examine their functional role in SacB from B. 
megaterium. 
 
            W94A            W172A    N252A, N252D    R256A 
     D95A          L118A         S173A     N252G, N252H     D257A 
Gd    70 VWVWDTWTLIDKH  82   89 NGWEVIFCLTADP 101  160 QAEWSGSSRLMQ 171  240 QNEF----------FNFRDPFTFED 254 
Ps    42 VFIWDTMPLRELD  54   61 NGWSVIVTLTADR  73  128 TREWAGTPVLLN 139  194 QNST----------WNFRDPSPFID 210 
Ra    42 VFIWDTMPLRSLD  54   61 DGWSVIFTLTAQR  73  128 SREWAGTPILLN 139  194 QNPY----------WNFRDPSPFID 210 
Ea    42 VFIWDTMPLRDFD  54   61 NGWCIIFTLTADR  73  128 TREWAGTPILLN 139  194 QNAF----------WNFRDPSPFID 210 
Zm    40 LWLWDTWPLRDIN  52   59 KGWNVIFSLVADR  71  110 TAEWSGGTIMAP 121  183 ENNL----------WNFRDPHVFIN 199 
 
Ss   284 IDVWDSWPVQDAK 295  303 NGYQLVISMAGAP 315  352 DQQWSGSATVNS 363  424 KFMStf[11]rtdnYCLRDPHIIED 456 
Pp    91 FDVWDSWPLQNAD 103  110 KGYNIVFGLAGDP 122  169 SEEWSGSATLTS 180  245 QSVGvdm-----dnHTFRDPHYVED 265 
Ba    82 LDVWDSWPLQNAD  94  101 NGYHVVFALAGSP 113  160 TQEWSGSATFTS 171  229 QFIDegnyt-sgdnHTLRDPHYVED 253 
Sm   243 LDVWDSWPVQDAK 254  262 NGYQLVVAMMGIP 274  311 TQEWSGSATVNE 322  384 QWRStftg---adnIAMRDPHVIED 406 
Bs    56 LDVWDSWPLQNAD  68   75 HGYHIVFALAGDP  87  134 TQEWSGSATFTS 145  203 QFIDegnys-sgdnHTLRDPHYVED 227 
Bm    91 LDVWDSWPLQNAD 103  110 HGYQIVFALAGDP 122  169 TQEWSGSGTLTK 180  239 QFIDeggyd-tgdnHTLRDPHYIED 263 
 
        E350A 
       E352A   R370A          Y421A 
Gd   333 ANCVNDQTERPQVYLHNGKYYIFTISHRTTFA 363 420 FQSYSHYVMPG 430 
Ps   279 AVGVNDQTERPHYVFQDGKYYLFTISHKFTYA 309 349 FQTYSHCVMPN 359 
Ra   279 AVGVNDQTERPHFVFQDGKYYLFTISHKFTYA 309 349 FQTYSHCVMPN 359 
Ea   279 AVGVNDQTERPHFVFQDGKYYLFTISHKYTFA 309 349 FQTYSHYVMPN 359 
Zm   268 AFGVNDQMERPHVIFQNGLTYLFTISHDSTYA 298 339 TEAYAHYIMNN 349 
 
Ss   539 SHMVTDEVERPSVVKMGGKYYLFTASRINKST 569 620 TSTYSYYAVPV 630 
Pp   346 SNLVTDEIERANVFKMNGLWYLFTSTRGSKVT 376 420 TWTYAHFAIPQ 430 
Ba   334 SNTVTDEIERANVFKMNGKWYLFTDSRGSKMT 364 408 TFTYSHFAVPQ 418 
Sm   491 STMVSDELERPNVVKLGDKYYLFTASRLNHGS 521 572 TATYSYYAVPV 582 
Bs   304 SNTVTDEIERANVFKMNGKWYLFTDSRGSKMT 334 382 TFTYSHFAVPQ 392 
Bm   344 SNTVTDEIERANIFKKDGKWYLFTDSRGSKMT 374 418 TFTYSHFAVPQ 428 
 
Figure 41 Sequence alignment of related levansucrases. Gd is Gluconacetobacter 
diazotrophicus (Martinez-Fleites et al., 2005), Ps is Pseudomonas syringae (Hettwer 
et al., 1998), Ra is  Rahnella aquatilis (Song et al., 1998), Ea is  Erwinia amylovora 
(Geier et al., 1993), Zm is  Zymomonas mobilis (Song et al., 1994), Ss is  
Streptococcus salivarius (Rathsam et al., 1993), Pp is Paenibacillus polymyxa 
(Bezzate et al., 2000), Ba is Bacillus amyloliquefaciens (Tang et al., 1990), Sm is 
Streptococcus mutans (Ueda et al., 1988), Bs is Bacillus subtilis (Meng et al., 2003), 
Bm is Bacillus megaterium. The amino acids used for the mutagenesis study are 
indicated and the resulting variant is labelled above the sequence. N252 (B. 
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megaterium numbering) which is not located in the active site was identified by a 
random mutagenesis screen (Beine et al., 2008). 
 
Table 18 Postulated functions of chosen amino acid residues located in the 
active site of the fructosyltransferase SacB from B. megaterium. The effect of the 
functional knock-out of the amino acid residues is studied by an exchange to alanine. 
Postulated function Bacillus 
megaterium 
numbering 
Bacillus subtilis 
numbering 
Interactions 
with sucrose 
Nucleophile Asp95 Asp86 1’-OH 2.86 
C-2’ 3.1 
Stabilisation Glu350 Glu340 4-OH 2.45,  
3-OH 2.83 
Polymer synthesis Arg370 Arg360 3-OH 3.14,  
2-OH 3.23 
Stabilisation Tyr421 Tyr411 2-OH 2.93 
Acid/base catalyst Glu352 Glu342 1-O 2.75,  
2-OH 3.00,  
3’-OH 2.75 
Stabilisation Trp94 Trp85 6’-OH 3.09 
Stabilisation Asp257 Asp247 4’-OH 2.76,  
3’-OH 2.85 
Poly/oligosaccharide 
synthesis 
Arg256 Arg246 3’-OH 2.80 
 Trp172 Trp163 - 
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 Ser173 Ser164 - 
 Leu 118 Leu109 - 
 Val115 Val106 - 
Screen for polymer 
formation 
Asn252 Asn242 - 
 
The amino acid residue Asn in position 242 was identified in a random mutagenesis 
screen of the levansucrase from B. subtilis to have a strong impact on 
transfructosylation. An exchange to alanine abolishes polymer formation. Sequence 
alignments and the structure from the fructosyltransferase SacB from B. megaterium 
shows that Asn252 is the analogous amino acid.  
 
4.3.2 Identification of amino acid residues not located in the active site 
with potential impact on the linkage type of the synthesised oligo- 
and polysaccharides 
In a sequence alignment with the inulosucrase from Lactobacillus reuteri, amino acid 
residues of the fructosyltransferase SacB from B. megaterium with impact on the 
linkage type formation of the fructosyl moieties of the formed oligo- and 
polysaccharide were identified. In contrast to the fructosyltransferase SacB from B. 
megaterium which synthesises β-(2,6)-linked levan, the inulosucrase from Lb. reuteri 
synthesises oligo- and polyfructosides with β-(2,1)-linkages (figure 42). As an attempt 
to control the linkage type of the oligo- and polyfructosides formed by the 
fructosyltransferase SacB from B. megaterium, the analogous amino acid residues 
were exchanged to the corresponding inulosucrase amino acid residues from Lb. 
reuteri (table 19). 
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Figure 42 Structures of β–(2,1) linked inulin and β-(2,6) linked levan. 
 
Table 19 Sequence aligment of SacB from B. megaterium (Bm) with the 
inulosucrase from Lb. reuteri (Lr). 
Levansucrase Bm  Inulosucrase Lr  
Y247  [Gap]  
N312  D  
K315  R  
S372  N  
K373  R  
Q381  [Gap]  
H423  Y  
Y439  Y  
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4.3.3 Identification of amino acid residues not located in the active site 
with impact on the transfer versus hydrolysis activity 
By sequence blasts and structural alignments of the fructosyltransferase from 
Bacillus megaterium with already crystallised fructosyltransferases from Bacillus 
subtilis, Gluconacetobacter diazotrophicus and an exo-inulinase from Aspergillus 
awamori (for kinetic data see table 20) we identified eight amino acids with potential 
impact on the transfructosylation versus hydrolysis process (table 21). The identified 
amino acid residues were chosen because of their location on the surface of SacB 
from B. megaterium (figure 43). 
 
Table 20 Kinetic data of sucrose-active enzymes from Clan-j GH 32 (Aspergillus 
awamori) and GH 68 (Bacillus subtilis and B. megaterium, Lactobacillus reuteri and 
Gluconacetobacter diazotrophicus). 
Organism Reaction conditions Km kcat 
Bacillus megaterium (this study) pH 6.6, 37 °C 6.6 2272 
Bacillus subtilis (Chambert et al., 1991) pH 6.0, 30 °C 40 0.583 
Gluconacetobacter  
diazotrophicus (Martinez-Fleites et al., 2005) 
pH 5.0, 30 °C 11.9 1 
Lactobacillus reuteri (Kralj et al., 2004) pH 5.4, 37 °C 9.7 147 
Aspergillus awamori (Kulminskaya et al., 2003) pH 4.5, 37 °C 40 1150 
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Table 21 Amino acids outside the active site with impact on the 
transfructosylation process. 
Amino 
acid  
Exchange to  Variant  Postulated function  
Y247  Alanin, Isoleucin, 
Tryptophan  
Y247A, Y247I, 
Y247W  
Polymer formation, (2-6) 
stereoselectivity  
N312  Alanin  N312A  Polymer formation 
K315  Alanin, Arginin  K315A, K315R  Polymer formation 
S372  Alanin  S372A  Polymer formation 
K373  Alanin, Arginin  K373A, K373R  Polymer formation, (2-1) 
stereoselectivity  
Q381  Alanin  Q381A  Polymer formation, (2-1) 
Stereoselectivity  
H423  Alanin, Tyrosin  H423A, H423Y  (2-1) stereoselectivity  
Y439  Alanin  Y439A  (2-1) stereoselectivity  
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Figure 43 Location of the amino acid residues of the fructosyltransferase SacB 
from B. megaterium not located in the active site which were identified by sequence 
and structural alignments with other fructosyltransferases from Aspergillus awamori, 
Bacillus subtilis, B. megaterium, Lactobacillus reuteri and Gluconacetobacter 
diazotrophicus. 
 
4.3.3 Functional role of the exchanged amino acids located in the active 
site and insights into the reaction mechanism of the 
fructosyltransferase SacB from Bacillus megaterium 
Levansucrases belong to glycoside hydrolase family (GH) 68 according to CAZy 
(Cantarel et al., 2009) which bind the substrate sucrose in subsite -1 (fructosyl 
residue) and +1 (glucosyl residue). In this family, two X-ray structures of the B. 
subtilis and G. diazotrophicus fructosyltransferases have been elucidated and both 
show a five-fold β-propeller topology (Meng et al., 2003; Martinez-Fleites et al., 
2005). 
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The enzyme variants were incubated with sucrose (500 mM) for 72 h at 37 °C in 
Sörensen`s buffer, 50 mM, pH 6.6 and analysed by TLC (figures 44 and 45). 
 
 
Figure 44 TLC analysis of the product spectrum of the wild-type 
fructosyltransferase SacB from B. megaterium and its variants of amino acid residues 
located in the active site after 24 h reaction time. Fru is fructose, Glc, is glucose, OS, 
is oligosaccharide, PS is polysaccharide. 
 
Table 22 Product spectrum of the wild-type fructosyltransferase SacB from B. 
megaterium and indicated variants after 60 min reaction time. All values are given in 
mM. The sample used for the identification of neokestose is indicated. 
  wild-type  L118A W172A N252A N252D N252G N252H R370A Y421A 
glc 428.0 85.1 13.0 447.9 463.4 334.9 118.6 138.7 12.2 
fru 292.2 71.6 11.3 391.4 362.0 279.9 102.3 103.0 9.6 
suc 41.9 407.1 487.0 17.1 0.0 141.8 381.4 321.3 487.5 
1-kestose 15.9 3.4 0.0 5.2 3.5 6.9 0.0 3.4 0.0 
α,β-blastose 6.4 0.0 0.0 7.3 17.3 9.7 0.0 3.9 0.0 
6-kestose 3.5 0.0 0.0 15.0 4.2 6.8 0.0 0.0 0.0 
neokestose 2.8 3.5 0.0 5.8 7.4 6.6 0.0 32.7 0.0 
nystose 1.5 0.5 0.0 1.7 4.1 0.0 0.0 0.0 0.0 
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Table 23 Product spectrum of the wild-type fructosyltransferase SacB from B. 
megaterium and indicated variants after 19 h reaction time. All values are mM. The 
sample used for the identification of blastose is indicated. 
  wild-type  L118A W172A N252A N252D N252G N252H R370A Y421A 
glc 449.8 304.1 101.1 459.9 443.8 448.7 431.1 414.4 97.8 
fru 359.8 226.7 89.5 399.4 375.5 360.3 360.3 357.2 83.8 
suc 0.0 172.2 389.7 0.0 0.0 0.0 27.4 0.0 389.5 
1-kestose 7.6 4.5 2.1 4.0 7.7 7.0 6.0 6.0 4.7 
α,β-blastose 24.5 7.4 1.1 14.1 21.5 26.3 16.7 69.7 1.1 
6-kestose 4.9 4.1 0.6 11.9 14.8 6.7 4.5 1.2 0.0 
neokestose 9.5 5.3 5.4 7.0 9.3 15.0 12.3 13.6 6.9 
nystose 3.7 2.5 0.0 3.2 3.5 3.4 2.1 2.1 0.0 
 
Amino acid sequence alignments of various levansucrase enzymes (figure 41) in 
combination with structural data of the family GH 32 members pointed towards 
functional relevant residues located in the active site of the fructosyltransferase SacB 
from B. megaterium. Subsequent site-directed mutagenesis of Trp94, Asp95, Val115, 
Leu118, Trp172, Ser173, Arg256, Asp257, Glu350, Glu352, Arg370 and Tyr421 was 
performed in order to explore the structural determinants which are responsible for 
the transfructosylation activity in B. megaterium SacB. 
The residues Asp95, Glu352 and Asp257 are proposed to form the catalytic triad of 
the fructosyltransferase SacB from B. megaterium (figures 38 to 40). The substitution 
of Asp95 with alanine inhibited the enzyme activity (figure 44). Sequence alignments 
with other levansucrases from various bacteria as well as the structural information 
from the fructosyltransferase SacB from B. megaterium show that this amino acid 
residue acts as the nucleophile. It attacks the fructofuranosyl residue of the sucrose 
and forms an enzyme-fructosyl intermediate. The corresponding acid/base catalyst 
was Glu352. Consequently, an exchange to alanine led to a kock-out of the enzyme 
activity. The variant D257A also showed almost no activity. The residue Asp257 
coordinates the fructofuranosly moiety in positions 3-OH and 4-OH. 
Trp94, Arg256, Glu350, and Tyr421 were selected according to their corresponding 
amino acid residues of the SacB from B. subtilis (Chambert et al., 1991; Meng et al., 
2003) which form hydrogen bonds to sucrose and position it in a productive 
orientation. Here, the substitution with alanine of each of these amino acid residues 
in the fructosyltransferase SacB from B. megaterium showed different effects. The 
variants R256A and E350A were nearly inactive. This agrees with the structural 
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information obtained for SacB from B. subtilis where the corresponding Arg246 
formed hydrogen bonds to the 3-OH of the fructofuranoside and also to 4-OH of the 
glucopyranoside while Glu340 (B. subtilis SacB numbering) coordinated the 3-OH 
and 4-OH of the glucopyranoside. The SacB variant W94A from B. megaterium still 
carried 9 % of the catalytic efficiency (kcat/Km) while variant Y421A showed just 3 % of 
the wild-type activity. Considering the X-ray structure of SacB from B. subtilis, this 
Trp formed a hydrogen bond with 6-OH of the fructofuranoside and Tyr of the 2-OH 
of the glucopyranoside. Due to the low reaction rate hydrolysis was predominantly 
observed (tables 22 and 23). The substituted amino acid residues Trp172 and 
Ser173 were proposed to be part of interactions with amino acids of the active site. In 
the fructosyltransferase SacB from B. subtilis, this Trp forms a pocket for the 
glucopyranoside of the C-6-OH. The experiments with the SacB variant W172A from 
B. megaterium showed a 72-fold increase of the Km and thus confirmed this function. 
It was very interesting to notice that subsitution of Ser in position 173 by alanine 
effected the catalytic efficiency dramatically, while the Km was comparable to the 
wild-type SacB (table 24). Thus, it is proposed that Ser173 does not influence the 
binding mode of sucrose, but it must somehow participate in the subsequent 
catalysis. 
 
4.3.4 Structure-functional aspects of the fructosyltransferase SacB from 
Bacillus megaterium - Hydrolysis versus fructosyl transfer 
The substitution of Arg370 with alanine of B. megaterium SacB resulted in 
fundamental changes in product formation. The corresponding residue in SacB from 
B. subtilis in subsite -1 (Arg360), was previously described as a key residue for the 
formation of 1-kestose (Chambert et al., 1991; Meng et al., 2003). We observed the 
time-dependent accumulation of different oligosaccharides during the correspondent 
B. megaterium SacB variant R370A catalysis. After 60 min reaction time an 
accumulation of neokestose (2,6-β-Fru-α-Glc-1,2-β-Fru, 32.7 mM) was determined 
while after 19 h blastose (2,6-β-Fru-α,βGlc) was the main reaction product (69.7 
mM). A four-fold Km-value decrease compared to the wild-type enzyme supported the 
interactions of Arg370 with the 2-OH and 3-OH of the glucosyl residue in the active 
site. It is possible that the substitution to Ala favoured an unspecific substrate binding 
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and enabled a fructosylation at C-6 of the glucosyl residue of sucrose yielding 
neokestose. When the trisaccharide neokestose was accumulating and entering the 
active site of SacB variant R370A, the β-(2,1)-linkage is cleaved leading to the 
hydrolyzation product blastose. Blastose was supposed to be no donor substrate of 
the enzyme indicated by its strong accumulation due to an unfavourable β-(2,6)-
linkage between glucose and fructose. 
Residue Asn252 obviously plays an important role for the transfructosylation process 
of the fructosyltransferase SacB from B. megaterium. A substitution to Ala or Gly 
completely stopped the polysaccharide production at all, while the Km and kcat values 
were not affected (table 24). Catalysis of this variant was switched from mainly 
polysaccharide synthesis to hydrolysis (tables 22 and 23). In contrast, mutation of 
Asn252 to Asp252 affected just the downregulation of the polysaccharide synthesis 
(figure 45), also without changing Km and kcat values significantly. The X-ray structure 
of the fructosyltransferase SacB from B. megaterium enabled insights into the 
function of this amino acid residue. Due to its position in the +2-site, it stabilises the 
third fructosyl unit of the growing oligosaccharide chain and direct it as an acceptor 
substrate in the optimal position for further transfructosylation. 
The mutation of Asn in position 252 to Asp obviously reduced the coordination of a 
fructosyl unit in the +2-site. However, it was still possible to some extend as indicated 
by the formation of a little amount of polysaccharide (figure 45). The mutations to 
alanine, glycine and histidine led to a complete knock-out of the polysaccharide 
formation. Recently, Ozimek et al. proposed a model of the sugar-binding subsites in 
two Lb. reuteri 121 fructosyltransferases (Ozimek et al., 2006). For the fructan 
polymer synthesis, the subsites +2, and +3 need a high affinity for binding the 
growing fructan polymer chain. But no structural determinants have been reported so 
far.  
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Figure 45 TLC analysis of the product spectrum of the wild-type 
fructosyltransferase SacB from B. megaterium and the variants of N252 after 24h 
reaction time. Fru is fructose, Glc, is glucose, Os, is oligosaccharide, Ps is 
polysaccharide. 
 
The amino acid residues Arg370 and Asn252 which seem to be crucial for the 
polyfructan synthesis are found to be conserved in fructosyltransferases from Gram-
positive bacteria. In contrast, the endophytic Gram-negative bacterium G. 
diazotrophicus SRT4 secretes a constitutively expressed levansucrase (LsdA, EC 
2.4.1.10), which mainly converts sucrose into fructo-oligosaccharides. It contains a 
His419 instead of Arg370 at the equivalent position (figure 46). This His419 residue is 
found strictly conserved in Gram-negative levansucrases. Further, Asn252 is strictly 
conserved in Gram-positive bacteria while in Gram-negative ones this region shows 
variability. The corresponding part of the 3D-structure of LsdA was almost perfectly 
superimposable with the equivalent residues of the B. subtilis SacB in the active site. 
In contrast, the region +2 with the amino acid residue N252 was not perfectly 
superimposable (figure 46). 
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Figure 46 Local identification and alignment of the amino acid residues N252 and 
R370 from the fructosyltransferase SacB from B. megaterium crucial for polymer 
synthesis. SacB from Bacillus megaterium (Bm, rosé) and Gluconacetobacter 
diazotrophicus (Gd, grey) (Martinez-Fleites et al., 2005) with sucrose in the active site 
are shown. 
 
It was shown for the first time that a single amino acid substitution at the +2-subsite 
switches the enzymatic reaction from poly- to oligosaccharide formation conserving a 
high enzyme activity by changing from a processive to a non-processive mechanism. 
Based on these studies in the following chapters more structural details of the +2- 
and +3-subsites enable the redesign of this enzyme for the synthesis of tailor-made 
short-chain fructo-oligosaccharides. 
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Table 24 Kinetic parameters of the wild-type fructosyltransferase SacB from B. 
megaterium and its variants. The amino acids located in the active site are indicated 
in red. Mutations in subsite +2 and further away from the active site are shown in 
green colour. 
Variant 
Km 
[mM] 
kcat 
[s-1] 
kcat/Km 
[mM-1 s-1] 
wild-type 6.6 ± 1.1 2272 346 
W94A 31.9 ± 11.0 1000 31 
D95A inactive inactive inactive 
L118A 66.6 ± 22.1 1231 19 
W172A 480.4 ± 124.8 2396 5 
S173A 2.3 ± 1.2 363 159 
Y247A 9.0 ± 1.6 1505 167 
Y247I 11.4 ± 3.0 2030 178 
Y247W 2.1 ± 1.3 2653 1263 
N252A 4.1 ± 1.7 1480 361 
N252D 8.4 ± 2.3 3743 445 
N252G 7.5 ± 0.8 2256 301 
N252H 35.1 ± 30.7 1529 44 
R256A inactive inactive inactive 
D257A inactive inactive inactive 
N312A 10.8 ± 3.0 776 72 
K315A 5.3 ± 2.0 2415 456 
K315R 9.5 ± 3.6 2122 223 
E350A inactive inactive inactive 
E352A inactive inactive inactive 
R370A 29.2 ± 11.6 179 6 
S372A 7.5 ± 2.4 2617 349 
K373A 3.5 ± 1.4 699 200 
K373R 11.0 ± 4.2 1708 155 
Q381A 9.5 ± 1.9 3295 347 
Y421A 51.9 ± 16.3 335 6 
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H423A 47.6 ± 8.4 2760 58 
H423Y 13.2 ± 3.8 1722 130 
 
 
4.3.5 The proposed reaction mechanism of the fructosyltransferase 
SacB from Bacillus megaterium 
The fructosyltransferase SacB from B. megaterium cleaves sucrose and, via a 
covalent intermediate, transfers the fructosyl moiety to water (hydrolysis) or a 
growing oligofructoside chain (transfructosylation). The glycosyl transfer reaction 
follows a retaining mechanism. The carboxyl group of the nucleophile Glu352 
protonates the glycosidic bond of sucrose. The formation of the enzyme-fructosyl-
intermediate is performed by a covalent bond between Asp95 and the C2 of the 
fructosyl moiety of sucrose. The intermediate is stabilised by Asp257. A 
conformational change from 3T4 to E4 is the consequence (T, twist; E, envelope). A 
nucleophilic attack at the C2 position leads to hydrolysis or fructosyl transfer. The 
proposed mechanism was supported by docking experiments (Seibel et al., 2006b). 
Asn252 most likely interacts with the oligofructoside chain supporting the 
transfructosylation process (Homann et al., 2007; figure 47). 
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Figure 47  The acceptor reaction mechanism. The mechanism is based on the 
fructosyltransferase SacB from B. megaterium with sucrose as substrate (Homann et 
al., 2007). 
 
4.3.6 Impact of the amino acid residues not located in the active site on 
the transfructosylation process catalysed by the 
fructosyltransferase SacB from Bacillus megaterium 
In a further investigation of amino acid residues influencing the transfructosylation 
process, 8 amino acid residues which are not located in the active site were 
identified. Variants were created based on sequence and structural alignments (table 
20). Martin Gamer from the group of Dieter Jahn (Department of Microbiology, TU 
Braunschweig) created 13 variants of the fructosyltransferase SacB from B. 
megaterium (table 21) which were expressed in E. coli. After purification by FPLC the 
variants were characterised kinetically. All SacB variants have a Km-value 
comparable to the wild-type except for H423A and Y439A. H423A has a seven-fold 
increased Km which indicates a significant conformational change of the active site. 
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Variant Y439A is inactive. The Km of the other variants differs from 2.1 (Y247W) to 
13.2 mM (H423Y). That is not more than 50 % difference from the Km of the wild-
type. This indicates that the active-site architecture is maintained keeping the wild-
type`s original substrate affinity.  
Also the kcat of all variants is comparable to the wild-type SacB, again except for two 
variants, K373A and N312A. These have a kcat of roughly factor three lower than the 
wild-type. However, this value is still high compared to fructosyltransferases from 
other organisms (table 20). The other variants do not differ more than 40 % from the 
wild-type SacB`s turnover number. 
For the first time we created variants of a fructosyltransferase with amino acid 
exchanges in positions away from the +1-site with high impact on the 
transfructosylation process. 12 out of 16 variants of amino acid residues not located 
in the active site (including the N252 variants) keep the wild-type`s substrate affinity 
and turnover rate while synthesising different mixtures of fructo-oligosaccharides 
(figure 48). 
 
 
Figure 48 TLC analysis of the oligo- and polysaccharide formation of the wild-type 
fructosyltransferase SacB from B. megaterium and its variants after 72 h. The variant 
Y439A does not form any polymer. 
 
Clear differences of the synthesised fructo-oligosaccharides are already visible by 
judging the intense of the TLC stain. The variant K373A hardly forms any oligo- or 
polysaccharide while variant K373R apparently does not form any transfructosylation 
product at all. Some of the variants have a lighter staining (T315R, Y247A, Y247I) 
and some a more intense compared to the wild-type SacB (S372A, T315A, Y247W, 
N312A). In order to elucidate their composition, the precipitated reaction products 
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were analysed by HPAEC. On the basis of a tetrasaccharide standard, the HPAEC 
peaks were assigned to the corresponding number of fructosyl units (figure 49). 
 
 
Figure 49 The standard HPAEC chromatogram up to the tetrasaccharide 1-
nystose. Standards analysed are Glc, glucose, Fru, fructose, Suc, sucrose, 1-kest, 1-
kestose and 1-nyst, 1-nystose. HPAEC was performed under the conditions for 
oligosaccharide analysis (table ???).  
 
The amino acids Y247 and K373 have a clear impact on the transfructosylation 
process. The exchange of the amino acid K373 to alanine and arginine has different 
effects on the product formation. Regarding the variant K373A, the formation of tri- 
and tetrasaccharides is lowered while the synthesis of penta- and hexasaccharides is 
slightly enhanced. The knock-out of the amino group leads to shorter 
oligosaccharides (5 fructosyl units) than the exchange to arginine. Here, an 
oligosaccharide of up to 7 units is synthesised (figures 50 and 51). 
K373 is located in the +2 subsite of the active site of SacB. There it interacts with 
R370 located in subsite +1. The HPAEC chromatogram data shows that variant 
K373A is not capable any more to position either arginine 370 nor any carbohydrate 
unit or -chain in the right position for further transfructosylation of more than 5 
fructosyl units. The reason for the discrepancy of the amino acid position and the 
oligosaccharide chain length may be because of other, i.e. weaker, possible 
interactions of carbohydrates on the enzyme`s surface. That theory is supported by 
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the exchange of lysine in position 373 to arginine. Interactions between the arginine 
and the amino acid network as well as carbohydrate units are possible although not 
the whole range of oligosaccharides can be synthesised compared to the wild-type 
chromatogram (figure 51). 
 
 
Figure 50 HPAEC analysis of the oligosaccharide product spectrum from the wild-
type fructosyltransferase SacB from B. megaterium (black) and variant K373A (red). 
 
 
Figure 51 HPAEC analysis of the oligosaccharide product spectrum from the wild-
type fructosyltransferase SacB from B. megaterium (black) and variant K373R (red). 
 
The exchange of the tyrosine in position 247 to alanine leads to the formation of 
shorter oligosaccharides (figure 52). Nona- and decasaccharides are enhanced and 
the transfructosylation stops after approximately 9 fructosyl units. The distribution of 
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oligosaccharides synthesised by SacB variant Y247A is the same for the product 
spectrum of the variant Y247I. In contrast, the exchange of tyrosine to tryptophan 
yields the same oligosaccharide pattern as the wild-type SacB (figure 53). The 
reason may be that an unpolar favoured π-π-stacking mechanism is possible with 
tyrosine as well as tryptophan but not with alanine or isoleucine. The position of Y247 
is supposed to be a key supporting function in an oligo- and polysaccharide-forming 
assembly line, possibly in collaboration with other interactions on the enzyme`s 
surface. 
 
 
Figure 52 HPAEC analysis of the oligosaccharides synthesised by the wild-type 
SacB (black) and variant Y247A (red). 
 
 
Figure 53 HPAEC analysis of the oligosaccharides synthesised by the wild-type 
SacB (black) and variant Y247W (red). 
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Interestingly, the hydrolysis activity of the variants is mostly enhanced compared to 
the wild-type except for H423Y and K315A (figure 56). According to its highly 
increased transfructosylation activity of 32 % (mol/mol), K315A forms significantly 
more oligosaccharides (figure 55). The Km and kcat of the variant are comparable to 
the wild-type SacB. Surprisingly, the exchange of lysine in position 315 to arginine 
does not have any effect that differs significantly from any wild-type parameter (figure 
54). 
The amino acid residue Lys315 is located in subsite +2 from the active site. It 
influences the formation of oligosaccharides apparently by indirect effects on other 
amino acid residues enhancing the oligofructoside formation. 
 
 
Figure 54 HPAEC analysis of the oligosaccharides synthesised by the wild-type 
SacB (black) and variant K315R (blue). 
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Figure 55 HPAEC analysis of the oligosaccharides synthesised by the wild-type 
SacB (black) and variant K315A (blue). 
 
While the exchange of the histidine to tyrosine in position 423 has almost no 
influence on the Km and kcat, the transfructosylation activity is raised by 26 % 
[mol/mol]. The variant H423A has a seven-fold increased Km while the kcat remains in 
the wild-type range. Both HPAEC analysis` of the oligofructosides do not show any 
differences compared to the wild-type SacB. 
The analysis of the absolute transfer and the enhancement of the transfer reaction 
elucidate the biochemical characteristics of the variants. The amount of glucose 
released which indicates hydrolysis was compared to the amount of free fructose. 
The difference must be transfer products (table 25, figure 56). The two variants with 
significantly enhanced transfer activity are H423Y (26 %) and K315A (32 %). The 
variants K315R and N312A show a hydrolysis/transfer activity similar to the wild-type. 
All other variants have an increased hydrolysis activity of up to 39 % (K373A). H423A 
and Y439A were inactive under the given reaction conditions. 
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Table 25 Concentrations of the hydrolysis products glucose (Glc) and fructose 
(Fru) determined by HPAEC. WT is the wild-type fructosyltransferase SacB from B. 
megaterium. 
 
Glc 
[mM] 
Fru  
[mM] 
WT 120 86 
N312A 119 91 
K315R 118 89 
K315A 110 63 
Y247A 121 97 
Y247I 123 101 
Y247W 130 91 
S372A 126 96 
K373R 115 102 
K373A 124 119 
Q381A 124 106 
H423Y 108 71 
 
 
Figure 56  Hydrolysis activity of the wild-type fructosyltransferase SacB from B. 
megaterium (WT) and its variants. Deviance from the wild-type in % (mol/mol). The 
carbohydrate concentrations were determined by HPAEC. 
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The combination of biochemical data and structural information provide insights into 
the transfructosylation process. Clearly, the previously described arginine in position 
370 interacts with the glucose unit in subsite +1. Our studies lead to the identification 
of many more amino acid residues not located in the active site. K373, N252 and 
Y247 form a nice platform for a possible stabilisation of the fructan chain. Although 
the biochemical data do not show definite abrogation of the polymerisation process, it 
is clearly visible that the variants K373A, N252A and Y247A synthesise unique 
mixtures of oligosaccharides of different chain length. With the help of the structural 
information, a clear subsite can be assigned to every amino acid residue (figures 57 
and 59). However, it remains unclear if the oligosaccharide chain has a conformation 
that places more than one fructosyl unit in one subsite of the enzyme or if the 
oligosaccharide chain interacts with even more amino acid residues on the surface of 
the fructosyltransferase. Most likely, there`s a co-operation between the enzyme`s 
surface interaction with and the interaction between the fructosyl units of the 
oligosaccharide chain.  
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Figure 57 Surface model of the SacB from B. megaterium variant D257A with 
sucrose modelled in the active site. The amino acids with impact on the 
transfructosylation process are labelled and indicated by color. 
 
The structural information along with the biochemical data suggests a possible 
attachment for the acceptor oligosaccharide chain on the surface of SacB. From the 
X-ray analysis` energy density data, it is observed that arginine in position 370 is 
flexible. The native enzyme shows an interaction of K373 with R370 (distance 3.13 Å) 
acting as a “fishhook” for the substrate sucrose already speculated by Meng and 
Fütterer. They crystallised the native enzyme and its substrate-bound conformation 
(Meng et al., 2003; Meng et al., 2008). The conformation of this arginine in the 
analogous position changes when the substrate sucrose binds in the active site. 
Furthermore, in the native conformation a π-π-stacking of the fructan chain with the 
now accessible hydrophobic pocket formed by Y421 and H423 is possible (figure 58). 
In the substrate-bound conformation of R370, this pocket is blocked enabling the 
hydrolysis of sucrose (figure 58). The biochemical data for the mutagenesis studies 
of Y421 and H423 shows nearly wild-type Km and kcat values for variant H423Y. The 
tyrosine obviously is able to mimick the unpolar stacking interactions naturally 
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performed by histidine in this position. The variants Y421A and H423A have an 
increased Km indicating a change in the active site interacting with the substrate 
sucrose. However, variant H423A keeps the wild-type turnover number.  
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Figure 58 Surface of the fructosyltransferase SacB from B. megaterium. The 
amino acids with significant impact on the polymer formation are labelled. A) 
Crystallised conformation of SacB variant D257A with no substrate in the active site. 
R370 possibly interacts with Y421 and K373. B) Alternative conformation of R370 
blocking the proposed stacking area formed by Y421. Sucrose is shown in the active 
centre. 
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Figure 59 Summary of the most important amino acid residues of the 
fructosyltransferase SacB from B. megaterium. 
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4.4 Controlling the linkage type of sucrose and sucrose 
analogues – Impact of substrate engineering on the 
sucrose isomerase from Protaminobacter rubrum 
A toolbox for the synthesis of tailor-made oligosaccharides is our aim. One step is the 
control of the carbohydrate linkage types. Here, we present the isomerisation of 
sucrose and a sucrose analogue, Gal-Fru, by the surcrose isomerase SmuA from P. 
rubrum (figure 60). Gal-Fru has been previously synthesised by a novel 
fructosyltransferase from B. megaterium according to the enzymatic synthesis by the 
fructosyltransferase from B. subtilis (Seibel et al., 2006b). 
Three sucrose isomerases, a trehalulose synthase from Klebsiella sp. LX3 (Zhang et 
al., 2003), an isomaltulose synthase from Pseudomonas mesoacidophilus (Ravaud et 
al., 2007) and a sucrose isomerase from Protaminobacter rubrum (Ravaud et al., 
2009) were previously crystallised and characterised. They belong to the large family 
GH13, which contains the well-characterised α-amylase. Also an oligo-(1,6)-
glucosidase from Neisseria belongs to this family. The structure is an 8-stranded α/β-
barrel containing the active site, interrupted by a ~70 amino acid calcium-binding 
domain protruding between β-strand 3 and α-helix 3, and a carboxyl-terminal β-barrel 
domain. Both structures contain the conserved catalytic triad with a glutamate acting 
as general acid/base catalyst. Both sucrose isomerases have a certain unspecificity 
concerning the formation of the isomerisation product. They form up to 90 % of 
isomaltulose or trehalulose respectively, depending on the bacterial strain. The 
sequences have an identity of 69 % and 80 % positive amino acids (figure 61). The 
sequence also shows an identity of 98 % compared to an α-glucosyltransferase from 
Klebsiella. Both structural informations show a central cavity for the disaccharide with 
a pair of phenyl residues on the entrance/exit (figure 64). Mutation of these 
phenylalanine shifts the enzyme to hydrolysis. The sucrose isomerase from P. 
rubrum contains a highly conserved active site and act via a double-displacement 
mechanism forming a glycosyl intermediate (Davies et al., 1995; Mosi et al., 1997; 
Yoshioka et al., 1997; Uitdehaag et al., 1999; Jensen et al., 2004). The catalytic triad 
of the sucrose isomerase from P. rubrum consists of the amino acid residues D214, 
E268 and D342 (figures 62 and 63). An aromatic clamp with impact on the hydrolysis 
versus transfructosylation activity has been described for GH 5 enzymes, i.e. the 
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fungal exo-glucanase subfamily (Cutfield et al., 1999) and an endocellulase (Ducros 
et al., 1995). In the sucrose isomerase from P. rubrum it is formed by the amino acid 
residues F270 and F294 (Ravaud et al., 2009; figure 64). 
Recent findings describe mutations of two arginine residues of the sucrose 
isomerase from Protaminobacter rubrum yielding variants which synthesise 
predominantly isomaltulose (6-O-α-D-glucopyranosyl-β-D-fructose). With addition of 
an acceptor, in the published experiment glucose, an acceptor reaction towards 
enhanced isomaltose synthesis is observed. Our study shows the potential of the 
sucrose isomerase from P. rubrum to synthesise novel isomaltulose analogues by 
substrate engineering approaches (figure 60). 
 
 
Figure 60 The isomerisation reaction catalysed by the sucrose isomerase (SI) 
from P. rubrum. A) The native reaction with sucrose as substrate yielding 
isomaltulose, B) the isomerisation of the sucrose analogue Gal-Fru (α-(1,2)-linkage) 
yielding the isomaltulose analogue (α-(1,6)-bound). 
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Figure  61 Alignment of the isomaltulose synthase from Klebsiella sp. LX3 and the 
trehalulose synthase from Pseudomonas mesoacidophila. Yellow background 
indicates the identical amino acid residues and in green the positive matches. 
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Figure  62 Structure of the sucrose isomerase SmuA from P. rubrum co-
crystallised with the inhibitor deoxynojirimycin. The catalytic triad is highlighted in 
magenta (Ravaud et al., 2009). 
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Figure  63 Adapted from Ravaud et al., 2009: The active site of the sucrose 
isomerase SmuA from P. rubrum cocrystalliysed with the inhibitor deoxynojirimycin. 
The catalytic triad (D214, E268, D342) is highlighted in magenta. 
 
   
Figure  64 The location of amino acid residue Phe270 in the active site of SmuA 
from P. rubrum with modelled sucrose. A) The closed and B) the open conformation 
of Phe270 in the native active site of P. rubrum. 
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4.4.1 Docking studies of the sucrose isomerase from Protaminobacter 
rubrum with the sucrose analogue Gal-Fru as substrate 
Our docking studies show a potential access for sucrose and sucrose analogues to 
the active site as well as possible conformations of the sucrose analogue Gal-Fru 
(figure 65). Docking studies were performed with the structure of the sucrose 
isomerase SmuA from P. rubrum. Sucrose and the sucrose analogue Gal-Fru were 
used as substrates. The results show the position of sucrose in the active site of the 
enzyme in a slightly different conformation compared to the cocrystallised sucrose in 
the active site of the highly similar trehalulose synthase from Pseudomonas 
mesoacidophila. This is potentially due to missing stacking interaction of the glucose 
moiety with a tyrosine in position 64 (SmuA numbering) which cannot be handled by 
the docking software. A comparison of the docked sucrose analogue Gal-Fru with the 
natural substrate sucrose shows a potential conformation slightly different to the 
crystallised sucrose. The pocket for the glucosyl or galactosyl moiety, respectively, in 
subsite -1 is limited by some unpolar and aromatic phenylalanine residues. Our 
docking results suggest that the axial O4 of the galactosyl residue is positioned like 
the O6 of glucose for maintaining the interaction with the transition state stabiliser 
D214 (figure 65). The O6 of the galactosyl is in the same position as the C6 of 
glucose thus not interfering sterically with adjacent amino acid residues (figure 65). 
The position of the glycosidic bond is also slightly shifted. It is estimated that in the 
case of Gal-Fru as a substrate D342 acts as the transition state stabiliser. In both 
figures, F270 positioned at the entrance/exit of the active site is shown.  
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Figure  65 The active site of the sucrose isomerase SmuA from P. rubrum. The 
catalytic triad is formed by the amino acid residues D214 (transition state stabilizer), 
E268 (acid/base catalyst) and D342 (substrate orientation). F270 at the entrance/exit 
of the active site is shown as an orientation. A) The docked conformations of the 
glucosyl (rosé) and galactosyl (green) moiety of the natural substrate sucrose and the 
sucrose analogue Gal-Fru. B) Only the atoms of the glycosidic linkage and their 
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interaction with the amino acid residues of the catalytic triad are shown (colour 
scheme as in A). The docking procedure was performed with Autodock 4 (Scripps 
Research Institute, LaJolla, CA). The figure was drawn by pymol (DeLano scientific). 
 
4.4.2 Substrate engineering of the sucrose isomerase from 
Protaminobacter rubrum 
The action of the wild-type sucrose isomerase (SI) from P. rubrum on sucrose and 
sucrose analogues was investigated. The sucrose isomerisation reaction was first 
analysed in terms of the concentration of alginate-immobilised cells (w/v), 
temperature and pH by TLC and HPAEC (figures 66 and 67). 
 
 
Figure 66 The isomaltulose synthesis was performed with sucrose isomerase 
(1:100 (w/v) of immobilized cells) at 37 °C and 500 mM of sucrose in Sörensen`s 
phosphate buffer, 50 mM, pH 6.6. 
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Figure 67 The sucrose isomerase SmuA from P. rubrum acting on sucrose (500 
mM) at 37 °C and 1:100 (w/v) immobilised cells in Sörensen`s phosphate buffer, 50 
mM, pH 6.6. Glc is glucose, Fru is fructose, Suc is sucrose and Pal is isomaltulose 
(synonymous to palatinose). 
 
The optimum yield of isomaltulose was 82 % after 3 h at 37 °C and 1:100 (w/v) 
immobilised cells in Sörensen`s phosphate buffer, 50 mM, pH 6.6. With the identical 
reaction parameters we investigated Gal-Fru as substrate for the sucrose isomerase. 
The TLC analysis was promising, a new band appeared lower than sucrose (figure 
68). 
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Figure 68 Formation of the isomaltulose analogue of Gal-Fru at 37°C and 
immobilised cells in a concentration of 1: 100 (w/v) in Sörensen`s phosphate buffer, 
50 mM, pH 6.6. 
 
Isolation of the molecule corresponding to the newly appeared band by silica and 
analysis by NMR proved the shift in the linkage type from α-(1,2) to α–(1,6). The 13C-
NMR data from isomaltulose (Thompson et al., 2001) and the carbon spectrum of the 
Gal-Fru isomer are almost identical (table 26, figures 69 and 70). That indicates a 
linkage shift of Gal-Fru to α–(1,6). In the 1H-NMR the H-4 of the galactosyl moiety 
was identified at 4.01 ppm as a doublet of a doublet with coupling constants of 3.71 
and 8.25 Hz. The signal of the H-1 of the anomeric centre of the galactosyl moiety 
resonates at 4.87 ppm as a doublet with a coupling constant of 3.76 Hz. Thus, it can 
be concluded that the isolated compound is the galactosyl-containing analogue of 
isomaltulose. 
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Table 26 13C data for the α-/β-(1,6) isomer of the sucrose analogue Gal-Fru. 
Carbon atom 
position 
Galactose isomer 
of isomaltulose, δC 
1 100.98 
2 74.10 
3 77.14 
4 72.25 
5 81.62 
6 63.26 
1´ 65.25 
2´ 104.43 
3´ 75.67 
4´ 74.59 
5´ 77.87 
6´ 70.50 
 
 
Figure 69 13C NMR spectrum of α-/β-isomaltulose synthesised by the sucrose 
isomerase from P. rubrum. 
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Figure 70 13C NMR spectrum of the α-/β-galactosylfructoside isomer synthesised 
by the sucrose isomerase from P. rubrum. 
 
Our results show the potential of the sucrose isomerase from P. rubrum in performing 
a shift of the linkage type of sucrose analogues (α-(1,2)-) to isomaltulose analogues 
(α-(1,6))-linkages. By optimisation of the enzyme concentration and the reaction 
temperature we were able to follow the isomerisation reaction by TLC. Not only 
sucrose but also the sucrose analogue Gal-Fru was isomerised. The described 
potential of the enzyme to perform acceptor reactions when the arginine residues in 
position 325 and 328 are exchanged remains to be investigated. 
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4.5 Synthesis and physiological properties of novel 
fructo-oligosaccharides 
Fructo-oligo- and polysaccharides have been known for several years as prebiotics. 
The growth of beneficial gut bacteria like Lactobacilli and Bifidobacteria is stimulated 
by these carbohydrate structures. Fructosyltransferases like inulosucrases and 
levansucrases which utilise fructans of various chain lengths as substrates are 
common in many different bacteria. However, although the structure of the 
levansucrase SacB from Bacillus subtilis was solved, the mechanism of fructosyl 
transfer and hydrolysis could not be elucidated until today. The reaction conditions 
like substrate concentration play a crucial role which products are formed. It was 
shown that the fructosyltransferases from B. subtilis and B. megaterium is able to 
synthesise sucrose analogues (Seibel et al., 2006b). These act as substrates for the 
fructosyltransferase Suc1 from Aspergillus niger which synthesises defined kestose 
and nystose analogues (figure 71).  
 
 
Figure 71 Fructo-oligosaccharide target structures. I) Established product on the 
market (1-kestose and 1-nystose). II) 1-kestose (Man-(Fru2) or 1-nystose (Man-(Fru3) 
analogue, III) 1-kestose (Gal-(Fru)2) or nystose (Gal-(Fru)3) analogue. IV) 1-kestose 
(Fuc-(Fru)2) or 1-nystose (Fuc-(Fru)3) analogue. V) 1-kestose (Xyl-(Fru)2) or 1-
nystose (Xyl-(Fru)3) analogue. 
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The fructo-oligosaccharides were synthesised in order to be tested as substrates for 
beneficial gut bacteria and as immuno-stimulating agents in cultivations of human 
Caco-2 epithelial colorectal adenocarcinoma cells. The immunological response is 
the secretion of cytokines which have either direct or indirect influence on the 
activation of the immune system. Stimulation of the immune system by these novel 
pharmaceuticals can be useful to analyse inflammation processes. As auto-immune 
diseases like allergies are a growing problem in developed countries, specific 
stimulation of the immune system may prove useful to reduce this problem. 
 
4.5.1 Synthesis of sucrose analogues by the fructosyltransferase SacB 
from Bacillus megaterium 
The sucrose analogues were synthesized by a newly identified fructosyltransferase 
from Bacillus megaterium. B. megaterium is a rod-shaped Gram-positive soil 
bacterium. The fructosyltransferase SacB from B. megaterium was classified as EC 
2.4.1.9 and GH 13 according to CAZy.  
The synthesis of sucrose analogues was performed according to the synthesis of 
sucrose analogues with the fructosyltransferase SacB from B. subtilis published 
previously (Seibel et al., 2006b). Briefly, the fructosyl moiety of sucrose is transferred 
to an acceptor monosaccharide of choice, e.g. mannose, galactose, xylose or fucose 
(figure 72). The acceptor reaction was performed with two-molar excess of the 
acceptor in Sörensen`s phosphate buffer (50 mM) at pH 6.6 and 37 °C. Purified 
enzyme in a concentration of about 10 mg l-1 or crude cell extract in an appropriate 
dilution was used. The acceptor reaction was followed by TLC (figure 73). 
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Figure 72 The synthesis of sucrose analogues performed by the 
fructosyltransferase SacB from B. megaterium. 
 
 
Figure 73 TLC analysis of the synthesis of the sucrose analogue xylosyl-
fructoside (Xyl-Fru). The optimal time points for the best Xyl-Fru yield are boxed. 
 
The resulting sucrose analogues were purified by silica columns.The products were 
analysed with standards by HPAEC. All the indicated target disaccharides as 
precursors for the synthesis of the novel fructo-oligosaccharides were synthesised 
(figure 71). 
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4.5.2 The fructosyltransferase Suc1 from Aspergillus niger 
Cloning and expression of the fructosyltransferase Suc1 from Aspergillus niger was 
performed as previously described in cooperation with the group of Petra Dersch 
(Helmholtz-Centre for Infection Research) (Zuccaro et al., 2008). Briefly, Suc1 from 
Aspergillus niger strain AB1.13 was identified after addition of sucrose to the growth 
medium. The gene of Suc1 was identified in the group of Petra Dersch (Department 
of Microbiology, TU Braunschweig and Helmholtz-Centre for Infection Research), 
amplified and cloned into the vector ANIp8 yielding the plasmid pSKAn1015. The 
plasmid was transformed back into the A. niger strain. An extract from a cultivation 
with the transformed A. niger pSKA1015 was analysed by SDS-PAGE. A band was 
identified at 120 kDa. The theoretical size of Suc1 calculated on the basis of the 
amino acid sequence is approximately 60 kDa. It is estimated that the difference in 
the molecular weight is due to post-translational modifications like glycosylation.  
 
 
Figure 74 SDS-PAGE analysis of the culture supernatant from an A. niger 
SKAn1015 cultivation. The molecular weight of the standard proteins is indicated in 
kDa. Suc1 has an apparent molecular weight of about 120 kDa. 
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4.5.3 Purification of the fructosyltransferase Suc1 from Aspergillus niger 
The purification of the fructosyltransferase Suc1 was performed as described in the 
methods part (3.7.9). FPLC size-exclusion chromatography was used for seperation 
of the proteins from the supernatant of the A. niger pSKAn1015 cultivation. The 
chromatogram shows 3 peaks (figure 75) most likely corresponding to the three 
bands visible on the gel from the SDS-PAGE analysis (figure 74). 
 
 
Figure 75 FPLC chromatogram of the Suc1 purification. Purification was 
performed by size-exclusion with Sephadex 200 (Invitrogen). 
 
The activity test on sucrose of the peak fractions was performed according to the 
protocol described in the methods part (3.7.11). The TLC analysis shows the highest 
activity for the fractions 4 and 5 which are part of the peak indicated by “6” in the 
chromatogram (figure 76). 
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Figure 76 TLC analysis of the acitivity of the FPLC fractions peak fractions (figure 
75) incubated with sucrose (500 mM) for 3 h at 40 °C, pH 5.6. The enzyme 
concentration was 1/20 of the reaction volume. 
 
According to the results of the activity test (figure 76), the FPLC fractions 4 and 5 
were mixed and analysed by SDS-PAGE (figure 77). 
 
 
Figure 77 SDS-PAGE of the purified Suc1 with an apparent molecular weight of 
approximately 120 kDa. The molecular weight of the standard proteins is given in 
kDa. 
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4.5.4 Functional analysis of the glycosylation pattern of the 
fructosyltransferase Suc1 from Aspergillus niger 
The apparent molecular weight of the fructosyltransferase Suc1 from A. niger was 
120 kDa. It was assumed that the discrepancy to the theoretical molecular weight of 
60 kDa is due to post-translational modifications. Glycosylation can lead to much 
higher molecular weights of proteins. The N-glycosylation motifs are generally large 
glycan patterns common for post-translational modifications of glycoproteins (figure 
78). 
 
Figure 78 Simplified structure of the N-glycan core linked to an asparagine 
residue (N) of the sequon N-X-S/T. The blue squares are N-acetylglucosamine and 
the green circles are mannose. At the mannose residues R and R` further glycans 
may be attached yielding possibly large glycosylation motifs, e.g. high-mannose- or 
complex-type glycans. 
 
In order to prove the glycosylation of Suc1, PNGase F was used to deglycosylate 
Suc1. After 24 h incubation, the PNGaseF digestion yielded a protein band in the 
range of the proposed size of deglycosylated Suc1 when analysed by SDS-PAGE 
(figure 79). The reason why the band is not seen in the range of the theoretical mass 
of 62 kDa may be due to altered migration characteristics compared to the standard 
proteins. Recently an altered SDS loading capacity was described for certain 
membrane proteins (Rath et al., 2009). An activity test of the protein corresponding to 
this band proved it to be the deglycosylated Suc1 (figure 80). 
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Figure 79 SDS-PAGE analysis of the deglycosylation of the fructosyltransferase 
Suc1 from A. niger. The left lane is the native purified Suc1, the middle lane is the 
deglycosylated protein. The right lane shows the standard [kDa]. 
 
An activity test of the native Suc1 and the deglycosylated form clarified whether the 
glycosylation pattern has any influence on the product formation activity. The test 
was performed according to the protocol described in the methods part (pH 5.6, 40 
°C, 500 mM sucrose and 1/20 volume Suc1). 
 
 
Figure 80 Activity test of the native glycoform and the deglycosylated Suc1. 1-
kestose and 1-nystose are still synthesised by the deglycosylated Suc1. 
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In order to analyse the structure of the Suc1 and its mechanism of fructosyl transfer a 
structure of the enzyme is necessary. As there is no 3D-structure of an inulosucrase 
available yet, the amino acid sequence was the basis for an in silico calculation of the 
Suc1 structure. The modelling was performed by the web-based software 
ESyPred3D (http://www.fundp.ac.be/sciences/biologie/urbm/bioinfo/esypred). 
The alignment of the fructosyltransferase Suc1 from A. niger with the exo-inulinase 
from A. awamori shows potential structural characteristics responsible for the transfer 
vs. hydrolysis reactions. The exo-inulinase which cleaves fructosyl moieties from a 
polysaccharide has a much smaller active site with an unpolar surface. Thus, an 
acceptor molecule can not attach to form acceptor products. The active site of Suc1 
is wider and consists of some polar amino acid residues allowing a potential 
attachment of an acceptor molecule (figure 81). 
 
       
Figure 81 Comparison of the active site surface area of the fructosyltransferase 
Suc1 from A. niger (left side, modelled with EsyPred3D) and the exo-inulinase from 
A. awamori crystallised with fructose in the active site (on the right). The surface of 
the Suc1 shows a wider active site with more possibilities for the attachment of an 
acceptor. 
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Possible N-glycosylation sites in comparison to an exo-inulinase from Aspergillus 
awamori were determined by the web-based software NetNGlyc (Center for 
Biological Sequence Analysis, Department of Systems Biology, Technical University 
of Denmark, http://www.cbs.dtu.dk/services/NetNGlyc) (figure 82). 
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         1                                                   50 
Exo-Inu  .......... .......... .........F NYDQPYRGQY HFS.PQKNWM 
   Suc1  MKLQTASVLL GSAAAASPSM QTRASVVIDY NVAPPNLSTL PNGSLFETWR 
 
         51                                                 100 
Exo-Inu  NDPNGLLYHN GTYHLFFQYN PGGIEWGNIS WGHAISEDLT HWEEKPVALL 
   Suc1  PRAHVLPPNG QIGDPCLHYT DPSTGLFHVG FLHDGSGISS ATTDDLATYK 
 
         101                                                150 
Exo-Inu  ARGFGSDVTE MYFSGSAVAD VN.NTSGFGK DGKTPLVAMY TSYYPVAQTL 
   Suc1  DLNQGNQVIV PGGINDPVAV FDGSVIPSGI NGLPTLLYTS VSYLPIHWSI 
 
         151                                                200 
Exo-Inu  PSGQTVQEDQ QSQSIAYSLD DGLTWTTYDA ANPVIPNPPS PYEAEYQNFR 
   Suc1  P....YTRGS ETQSLAVSSD GGSNFTKLDQ G.PVIPGPP. .FAYNVTAFR 
 
         201                                                250 
Exo-Inu  DPFVFW...H DE.....SQK WVVVTSIAEL HK.....LAI YTSDNLKDWK 
   Suc1  DPYVFQNPTL DSLLHSKNNT WYTVISGGLH GKGPAQFLYR QYDPDFQYWE 
 
         251                                                300 
Exo-Inu  LVSEFG..PY NAQGGVWECP GLVKLPLDSG NSTKWVITSG LNPG....GP 
   Suc1  FLGQWWHEPT NSTWGNGTWA GRWAFNFETG N.VFSLDEYG YNPHGQIFST 
 
         301                                                350 
Exo-Inu  PGTVGSGTQY FVGEFDGTTF TPDADTVYPG .N.....STA NWMDWGPDFY 
   Suc1  IGTEGSDQPV VPQLTSIHDM LWVSGNVSRN GSVSFTPNMA GFLDWGFSSY 
 
         351                                                400 
Exo-Inu  AAAG...... ....YNGLSL NDHVHIGWMN ..NWQYGANI PTYP..WRSA 
   Suc1  AAAGKVLPST SLPSTKSGAP DRFISYVWLS GDLFEQAEGF PTNQQNWTGT 
 
         401                                                450 
Exo-Inu  MAIPRHMALK TIGSKATLVQ QPQE..AWSS ISNKRPIYSR TFKTLSEGST 
   Suc1  LLLPRELRVL YIPNVVDNAL ARESGASWQV VSSDSSAGTV ELQTLGISIA 
 
         451                                                500 
Exo-Inu  NTTTTGETFK VDLSFSAKSK ASTFAIALRA SAN...FTEQ TLVGYDFAKQ 
   Suc1  RETKAALLSG TSFTESDRTL NSSGVVPFKR SPSEKFFVLS AQLSFPASAR 
 
         501                                                550 
Exo-Inu  QIFLDR...T HSGDVSFDET FASVYHGPLT PDSTGVVKLS IFVDRSSVEV 
   Suc1  GSGLKSGFQI LSSELESTTV YYQFSNESII VDRSNTSAAA RTTDGIDSSA 
 
         551                                             597 
Exo-Inu  FGGQGETTLT AQIFPSSDAV HARLASTGGT TEDVRADIYK IASTWN. 
   Suc1  EAGKLRLFDV LNGGEQAIET LDLTLVVDNS VLEIYANGRF ALSTWVR 
 
Figure 82 Sequence alignment and possible glycosylation sites of the modelled 
fructosyltransferase Suc1 from A. niger (blue, low score, and purple) and the exo-
inulinase from A. awamori (red). 
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The in silico glycosylation was performed by GlyProt 
(http://www.glycosciences.de/modeling/glyprot). 11 possible N-glycosylation sites 
were detected and 10 were supposed to be suitable based on the scoring function of 
GlyProt. Standard complex-type glycans were attached which increase the gyration 
radius of Suc1 by 42 % (table 27, figure 83). 
 
Table 27 Comparison of the native Suc1 with its glycoform calculated by GlyProt. 
The gyration radius increases by 42 %. 
Deglycosylated Suc1 Native Suc1 
22.9 32.4 
 
 
Figure 83 Glycosylated in silico model of the fructosyltransferase Suc1 from A. 
niger. The gyration radius increases by 42 %. 
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4.5.5 Synthesis of 1-kestose and 1-nystose by the fructosyltransferase 
Suc1 from Aspergillus niger 
The fructosyltransferase Suc1 from A. niger transfers the fructosyl moiety from 
sucrose to a sucrose acceptor synthesising 1-kestose and 1-nystose. By substrate 
engineering it also utilises sucrose analogues yielding 1-kestose and 1-nystose 
analogues (Zuccaro et al., 2008; figure 84). 
 
 
Figure 84 The transfer of a fructosyl moiety from sucrose or a sucrose analogue 
to another sucrose acceptor molecule or analogue. 
 
The acitivity of the supernatant from a cultivation of A. niger SKAN1015 on sucrose 
was tested in different dilutions (1:100 and 1:200) and analysed by TLC (figure 85). 
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Figure 85 Activity of the fructosyltransferase Suc 1 from A. niger. Dilutions of 
1:100 and 1:200 were investigated. The sucrose concentration was 500 mM. The 
sample time points are indicated in min.  
 
The fructosyl transfer vs. hydrolysis activity of the Suc1 from A. niger SKAn1015 is 
relatively high compared to other A. niger strains, e.g. the industrially used strain 
ATCC20611 (table 28). 
 
Table 28 Distribution of the transfructosylation (Ut) and hydrolytic activities (Uh) of 
fructosyltransferases similar to Suc1 from different organisms. 
Organism  Ut [U l
-1]  Uh [U l
-1]  Ut/Uh  
Aspergillus niger (SKANIp8)  1080 880 1.2 
Aspergillus niger (SKAn1015)  244000 11000 21 
A. niger ATCC20611  38800 2800 14 
A. niger NRRL4337  5700 2800 2 
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A. oryzae IAM-2609pp13  3500 500 7 
Aureobasidium pullulans  10600 1100 10 
 
 
4.5.6 Growth screen of Lactobacilli and Bifidobacteria incubated with 
fructo-oligosaccharides as potential prebiotics 
Four strains of Lactobacilli (Lb. fructosus, Lb. plantarum, Lb. fermentum and Lb. 
delbrueckii) and Bifidobacterium lactis were cultivated in semi-defined medium with 
the fructo-oligosaccharide to be examined as the sole carbon source. The results for 
the Lactobacilli were similar for each strain. Glucose and 1-kestose were the best 
carbon sources for promoting the growth of the examined bacteria. The slope and 
maximum of both curve fits are equal. The 1-nystose curve shows a growth delay at 
the beginning and an overall lower height. When grown in 75 mM of 1-nystose the 
optical density at 600 nm did not reach 0.6 (figure 86). 1-Kestose is apparently 
metabolised similar to the glucose consumption. The curve fits are nearly overlapping 
so just the fits for 1-kestose is shown in different concentrations being consistent with 
the given glucose concentrations.  
The results show a growth of each bacterial strain with the fructo-oligosaccharides as 
the sole carbon source. TLC analysis of the metabolisation products indicates the 
action of a fructosyltransferase or fructosidase hydrolysing 1-kestose and 1-nystose 
to sucrose (figure 87). The involvement of different enzymatic processes requiring 
different glycosidases leads to a later consumption and metabolisation of fructo-
oligosaccharides with more than two fructosyl moieties. Thus, it is likely that these 
structures persist longer in the intestinal tract and can potentially evoke effects like 
immuno-stimulation of gastrointestinal cells. 
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Figure 86 Lactobacillus delbrueckii growth curve fit. Glc, glucose. The 
concentrations of the investigated fructo-oligosaccharides are given in mM. 
 
 
Figure  87 Metabolisation of 1-nystose by Lb. delbrueckii and Lb. fructosus after 1 
and 24 hours. The starting concentration of 1-nystose (1-nyst) is indicated [mM]. 1-
kest is 1-kestose. 
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4.5.7 Synthesis of novel 1-kestose and 1-nystose analogues by the 
fructosyltransferase Suc1 from Aspergillus niger 
Suc1 is highly specific for the synthesis of defined 1-kestose and 1-nystose 
analogues depending on the reaction time and conditions. The reaction was 
performed at 40 °C in Sörensen`s phosphate buffer (50 mM) at pH 5.6. The substrate 
concentration was 500 mM. The yields were about 60 % for each analogue. The 
products were identified and analysed by TLC and HPAEC with appropriate 
standards (figure 88, table 29). 
 
 
Figure 88 Synthesis of the 1-kestose and 1-nystose analogues of Gal-Fru and 
Man-Fru by the fructosyltransferase Suc1 from A. niger at 45 °C in Sörensen`s 
phosphate buffer (50 mM) at pH 5.6. 
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Table 29 Reaction times and conversion of the novel oligofructosides 
synthesised by the fructosyltransferase Suc1 from A. niger. 
 t [min] Conversion [%] 
1-kestose (Glc-Fru2) 
1-nystose (Glc-Fru3) 
18 
60 
81 
93 
Man-Fru2 
Man-Fru3 
60 
180 
71 
87 
Gal-Fru2 
Gal-Fru3 
420 
960 
44 
65 
Xyl-Fru2 
Xyl-Fru3 
20 
120 
75 
94 
Fuc-Fru2 
Fuc-Fru3 
60 
120 
65 
88 
 
The combined action of the fructosyltransferase SacB from B. megaterium and the 
Suc1 from A. niger leads to a possible process for the synthesis of nutra- and 
pharmaceuticals (figure 89). The two production hosts are generally-regarded-as-
safe (GRAS) organisms approved for the synthesis of products consumed by 
humans.  
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Figure 89 Possible process for the synthesis of novel pharma-/nutraceuticals by 
the concerted action of the fructosyltransferases from B. megaterium and A. niger. 
 
4.5.8 Novel fructo-oligosaccharides as immuno-stimulating agents 
Fructo-oligosaccharides were tested as substrates for beneficial gut bacteria and as 
immuno-stimulating agents in cultivations of human epithelial adenocarcinoma cells 
(Caco-2; figure 90). Carbohydrate-protein interactions are known to have broad 
effects on eukaryotic cells.  
We examined the cytokine response of a human Caco-2 cell line (figure 90) after 
exposure to novel fructo-oligosaccharides (figure 71). The Caco-2 cell line is a model 
for the absorption of pharmacological products in the intestinal region (Artursson et 
al., 2001; Shah et al., 2006). Our strategy is to analyse and characterise the cytokine 
release into the growth medium in the presence of our novel oligosaccharides. A 
commercially available kit (Biosource, Invitrogen) gives access to the parallel 
analysis of 25 different cytokines and chemokines in one sample (Eotaxin, 
granulocyte macrophage colony stimulating factor (GM-CSF), Interferon (IFN)-α, IFN-
γ, interleukin (IL)-1RA, IL- 1β, IL-2, IL-2R, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-
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12p40/p70, IL-13, IL-15, IL-17, IP-10, monocyte chemotactic protein (MCP)-1, 
monokine induced by gamma interferon (MIG), macrophage inflammatory protein 
(MIP)-1α, MIP-1β, regulated upon activation, normal T-cell expressed and secreted 
(RANTES) and tumour necrosis factor (TNF)-α). They were detected by fluorescent 
antibody-coated beads and quantified by a secondary fluorescence-labelling process 
(figure 92). The cytokines analysed have either direct or indirect influence on the cell 
signalling cascades and the activation of the immune system. Direct influence may 
be the release of cytokines by a cell line when it is cultivated in the presence of the 
novel oligosaccharides. Indirect stimulation of the immune system by these novel 
pharmaceuticals may include the growth of certain beneficial bacteria which in turn 
act as immuno-stimulating agents. As auto-immune diseases like allergies are a 
growing problem in developed countries, specific stimulation of the immune system 
may prove useful to reduce this problem. 
 
 
Figure 90 The Caco-2 cell line in a 200-fold magnification. 
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Figure 71 Fructo-oligosaccharide target structures. I) Established product on the 
market. II) 1- kestose (Man-(Fru)2) or 1-nystose (Man-(Fru)3) analogue. III) 1-kestose 
(Gal-(Fru)2) or 1-nystose (Gal-(Fru)3) analogue. IV) 1-kestose (Fuc-(Fru)2) or 1-
nystose (Fuc-(Fru)3) analogue. V 1-kestose (Xyl-(Fru)2) or 1-nystose (Xyl-(Fru)3) 
analogue. 
 
 
Figure 91 The analysis principle of the 25-plex human cytokine analysis kit 
(Biosource). 
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4.5.8.1 Immuno-assay of the human epithelial colorectal 
adenocarcinoma cell line Caco-2 incubated with novel fructo-
oligosaccharides 
Novel fructo-oligosaccharides were tested as immuno-stimulating agents in 
cultivations of human epithelial colorectal adenocarcinoma cells (Caco-2). Caco-2 
cells were grown for 48 h in 24-well dishes containing the fructo-oligosaccharide to 
be investigated in a concentration of 25 µM (sucrose, palatinose, 1-kestose, 1-
nystose, Gal-Fru, Gal-Fru2, Man-Fru. Man-Fru2, Man-Fru3, Fuc-Fru, Fuc-Fru2, Fuc-
Fru3, Xyl-Fru, Xyl-Fru2 and Xyl-Fru3). Five-fold repeats of each carbohydrate ensured 
the significance of the results. 
 
Table 30 Fructo-oligosaccharides investigated in terms of immuno-stimulation. 
suc sucrose 
pala isomaltulose (palatinose) 
kest 1-kestose 
nyst 1-nystose 
GF, GF2 Gal-Fru, Gal-Fru2 
MF, MF2,3 Man-Fru, Man-Fru2,3 
FF, FF2,3 Fuc-Fru, Fuc-Fru2,3 
XF, XF2,3 Xyl-Fru, Xyl-Fru2,3 
 
For the fructo-oligosaccharide assay, Caco-2 cells at 80 % confluence were split in a 
ration of 1:10 and cultivated in 24-well dishes. Each well was supplied with the 
oligofructoside to be tested in a concentration of 25 µM. After 48 h the medium was 
collected for cytokine analysis. The assay was performed with a 25-plex human 
cytokine analysis kit according to the manufacturer`s instructions (Biosource, 
Invitrogen). Briefly, the supernatant medium was incubated with antibody-
functionalised beads and detected with biotinylated secondary antibodies. 
Streptavidin-R-phycoerythrin (RPE) was used as a fluorescence marker. The final 
analysis was performed by the luminex system (Quiagen) which recognises spectral 
properties of the beads and quantifies the bead load by the specific fluorescence 
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intensity. In the 96-well plate provided, we analysed 15 different oligosaccharides in 
five-fold repeats (sucrose, palatinose, 1-kestose, 1-nystose, Gal-Fru, Gal-Fru2, Man-
Fru. Man-Fru2, Man-Fru3, Fuc-Fru, Fuc-Fru2, Fuc-Fru3, Xyl-Fru, Xyl-Fru2 and Xyl-
Fru3). The concentrations of 25 different cytokines were analysed in each sample 
(Eotaxin, granulocyte macrophage colony stimulating factor (GM-CSF), Interferon 
(IFN)-α, IFN-γ, interleukin (IL)-1RA, IL- 1β, IL-2, IL-2R, IL-4, IL-5, IL-6, IL-7, IL-8, IL-
10, IL-12p40/p70, IL-13, IL-15, IL-17, IP-10, monocyte chemotactic protein (MCP)-1, 
monokine induced by gamma interferon (MIG), macrophage inflammatory protein 
(MIP)-1α, MIP-1β, regulated upon activation, normal T-cell expressed and secreted 
(RANTES) and tumour necrosis factor (TNF)-α). 
IL-8 and MCP-1 were the only cyto- or chemokines, respectively, which gave a 
significant response compared to the background. Both standard curve fits show a 
correlation of over 99 % (figures 92 and 93). The measured fluorescence intensities 
are in the linear part of the standard curve indicating the significance of the data. The 
other cytokines gave no significant response under these conditions. MCP-1 
generally shows a higher signal-to-background enhancement compared to the 
cultivation of Caco-2 cells without added carbohydrates (neg. or w/o feed). MCP-1 is 
up-regulated up to a factor of 2.7 (MF3, figures 96 and 97, table 32). Longer fructosyl 
moieties seem to enhance this effect. For 1-nystose (factor 2.1), Man-Fru3 (2.7), Fuc-
Fru3 (2.6) and Xyl-Fru3 (1.8) the release of MCP-1 is clearly triggered. The 
stimulation of IL-8 is also visible when the fucose-containing 1-nystose analogue 
FucFru3 is added (figures 94 and 95, table 31). An enhancement factor of 1.1 is 
detected. Also in the case of IL-8 longer fructosyl chains seem to enhance the 
release of this cytokine. In the samples containing 1-nystose, Gal-Fru2, Man-Fru3, 
Fuc-Fru3 and Xyl-Fru3 the highest concentration of IL-8 was detected. An interesting 
observation is the already high stimulation of IL-8 by sucrose. 
One crucial question arises: Why are just two significant cytokine responses 
observable? The novel oligosaccharides have no effect on most of the tested 
cytokines. Only two out of 25 show significant up-regulation. Obviously it is not 
necessary for a cell in the intestine to synthesise cytokines and thus trigger the 
immune system upon contact with natural molecules of the carbohydrate metabolism. 
But it is crucial to release cytokines when the cell contacts potentially harmful 
structures, e.g. pathogens. Our novel oligosaccharide structures might mimick some 
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of these pathogen effects on cells. Mannose and fucose derivatives are the 
compounds which evoke the highest stimulation of MCP-1 and IL-8. This might be 
due to their participation in natural cell-cell communication processes, e.g. as 
terminal carbohydrate units in the Lewis X motif. 
The experiment does not have a time-resolving component. The reaction time was 48 
h but a cytokine can be released in several hours. The reason why we detect IL-8 
and MCP-1 after 48 h might be due to their persisting synthesis or to another effect 
that leads to persistent release. An IL-8 accumulation was described in Weibel-
Palade bodies of endothelial cells, where it colocalises with the von-Willebrand factor 
involved in blood coagulation (Sadler, 1998; Wolff et al., 1998). There it is stored and 
released continuously upon repeated stimulation, for example by the novel 
oligosaccharide structures. Another explanation might be that MCP-1 triggers IL-8 
release. So it might also be a secondary stimulation effect. Why exactly MCP-1 is 
detectable after 48 h remains to be investigated. 
 
 
Figure 92 Standard curve fit for the luminex IL-8 analysis.  
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Figure 93 Standard curve fit for the luminex MCP-1 analysis. 
 
The results for IL-8 and MCP-1 were correlated with the standard curve fit and 
converted to ng ml-1. 
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Figure 94 The concentration of IL-8 incubated with the target fructo-
oligosaccharides and controls (table 30). The means of each dot plot column is 
indicated by a red bar. 
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Table 31 Factors of signal-to-background enhancement of the IL-8 release. 
Carbohydrate Factor 
w/o feed 0,00 
Suc 0,54 
Pala 0,25 
1-k 0,20 
1-n 0,30 
GF 0,00 
GF2 0,27 
MF 0,06 
MF2 0,07 
MF3 0,40 
FF 0,23 
FF2 0,34 
FF3 1,10 
XF 0,32 
XF2 0,53 
XF3 0,53 
      IL-8 
 
Figure 95 Factors of signal-to-background enhancement of the IL-8 concentration. 
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Figure 96 The concentration of MCP-1 incubated with the target fructo-
oligosaccharides and controls (table 30). The means of each dot plot column is 
indicated by a red bar. 
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Table 32 Factors of signal-to-background enhancement of the MCP-1 release. 
Carbohydrate Factor 
w/o feed 0,00 
Suc 0,96 
Pala 0,59 
1-k 0,22 
1-n 1,95 
GF 0,50 
GF2 0,81 
MF 0,82 
MF2 0,34 
MF3 2,72 
FF 0,79 
FF2 0,62 
FF3 2,58 
XF 0,91 
XF2 1,31 
XF3 1,54 
 
MCP-1 
 
Figure 97 Factors of signal-to-background enhancement of the MCP-1 
concentration. 
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4.6 Bioorthogonal metabolic engineering of HEp-2, CHO-
K1 and CHO lec 3.2.8.1 cell lines for the investigation 
of cell-cell recognition processes 
The surface of eukaryotic cells is highly decorated with glycan structures of various 
types forming the glycocalyx. Glycolipids and glycoproteins mediate cell-cell 
recognition and signal transduction processes (Varki, 2006). In 2002 Bertozzi and co-
workers showed that functionalised carbohydrates can be incorporated into cells in 
vitro (Saxon et al., 2002; Dube et al., 2003; figure 103). This process works by active 
transporters and diffusion procedures depending on the modification of the 
carbohydrates. Acetylated sugars can easily pass the cell membrane whereas 
neuraminic acid derivatives carrying no acetylated hydroxyl groups enter the cell by 
special transporter systems (Bardor et al., 2005). Acetylated monosaccharides are 
processed by unspecific deacetylases, activated by nucleotide transferases and 
metabolised by isomerases and epimerases (Prescher et al., 2006; Chang et al., 
2007; Codelli et al., 2008; Laughlin et al., 2008; Chang et al., 2009). These activated 
carbohydrates are incorporated into the natural carbohydrate patterns of the cell 
(figure 103). Some of the modified sugars are part of the glycosylated cell surface 
and therefore are accessible to chemical conversion without destruction of the cell. 
Depending on the modified carbohydrate added to the growth medium of the cell line 
or organism, N- or O-glycosylation patterns are addressed.  
 
4.6.1 The alkyne-azide “click reaction” – Copper-catalysed formation of 
(1,3)-triazoles 
Functionalised monosaccharides with azide or alkyne groups have been synthesised 
in our group (Riaz-ul-Qamar, 2007; Serim, 2008). The acetylated sugars are more 
hydrophobic than the deprotected ones and therefore can pass the cell membrane 
more easily. They are afterwards processed by unspecific deacetylases and 
incorporated into the carbohydrate metabolic system (Prescher et al., 2006). But also 
the deprotected sugars are incorporated into cells by membrane transporter systems 
(Bardor et al., 2005). 
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The metabolised modified sugars are subsequently labelled by fluorescent 
molecules. As described in the theoretical background part of the introduction, a 
molecule with an alkyne group can be quantitatively coupled to an azide group in the 
presence of Cu(I) and other catalysts by click chemistry (figure 98). However, there 
are some advantages and disadvantages in the use of this method in vivo. The 
strong advantage is the bioorthogonality of the alkyne and the azide. A drawback is 
the cytotoxicity of the copper catalyst and the organic solvent system. 
 
 
Figure 98 Labelling of azido-carbohydrates by an alkyne-functionalised 
fluorescence molecule by click chemistry. 
 
4.6.2 Functionalised carbohydrates for bioorthogonal metabolic 
engineering 
Four functionalised carbohydrates were synthesised chemically for the use in 
metabolic labelling studies, 2-azidoacetylamino-2-deoxy-(1,3,4,6)-tetraacetyl-β-D-
glucopyranoside (AcGlcNAz), 2-azidoacetylamino-2-deoxy-β-D-glucopyranoside 
(GlcNAz; Serim, 2008), N-azido-acetylneuraminic acid (NeuNAz) and N-(1-oxohex-
5inyl) neuraminic acid (NeuNHex; Riaz-ul-Qamar, 2007; figure 99).  
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Figure 99 Functionalised carbohydrates synthesised by Riaz-ul-Qamar and Serim 
for the metabolic labelling of eukaryotic cells (Riaz-ul-Qamar, 2007; Serim, 2008). 
 
4.6.3 In vitro promiscuity studies of a human neuraminic acid synthase 
In first studies towards metabolic cell labelling, a human neuraminic acid synthase 
was investigated in terms of engineered substrate promiscuity. The native reaction is 
the conversion of N-acetylglucosamine with pyruvate to neuraminic acid. 
The isomerisation of GlcNAc to the neuraminic acid synthase substrate ManNAc was 
performed by a shift to pH 10 (Blayer et al., 1999). The following enzyme reaction 
took place at the described optimal pH 7.5 and, interestingly, also at the alkaline pH 
of 10 used for the epimerisation (figures 101 and 102). Due to the low amounts of 
enzyme availability, 0.1 U corresponding to a theoretical full conversion of GlcNAc or 
ManNAc were used, respectively, with pyruvate to form neuraminic acid in between 
14 days. Sampling time was each day. However, the HPAEC analysis shows an 
optimal yield at 7 days reaction time (figure 102). 
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Figure 100 A) The native and B) engineered reaction of the human neuraminic acid 
synthase (NAS). 
 
Figure 101 HPAEC analysis of the native and engineered conversion of ManNAc 
(pH 7.5), GlcNAc (pH 10) or engineered GlcNAz (pH 10) and pyruvate to NeuNAc or 
NeuNAz, respectively, by the neuraminic acid synthase. 
156 
4.6.4 Metabolic labelling experiments of HEp-2 cells with functionalised 
carbohydrates 
Metabolic labelling of cell surfaces was established in order to study and characterise 
cell signalling and cell-cell interactions to examine inflammation and infection 
processes. The metabolic incorporation of functionalised carbohydrates was 
performed with HEp-2 cells. The carbohydrates were modified by introducing an 
azide or alkyne group and subsequent incubation with the cell lines indicated. The 
modified carbohydrates passed the natural carbohydrate biosynthetic pathway and 
were incorporated into the post-translational glycan patterns of proteins (figure 103). 
 
 
Figure 102 Incorporation of modified carbohydrates into the natural carbohydrate 
metabolic process of eukaryotic cells. 
 
HEp-2 cells were incubated in the appropriate medium suitable for the cell line. At 80 
% confluence they were split into 6-well plates with the appropriate medium 
containing the functionalised carbohydrates in a concentration of 25 µM (AcGlcNAz, 
GlcNAz, NeuNAz and NeuNHex). The subsequent click reaction for the fluorescent 
labelling of the cell surface was performed in 12-well microscopy slides (idbidi) with 
50 µl detached cells in PBS buffer and 250 µl of the appropriate medium for the 
reattachment of the cells. After 24 h the medium was removed and the cells were 
washed three times with PBS. The functionalised fluorescent detection molecule and 
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the conditions for the click reaction (CuSO4, sodium ascorbate and TBTA ligand) 
were applied in DMSO as solvent system. After one hour, the cells were analysed by 
fluorescence microscopy (phase contrast) or the appropriate wavelength for 
fluorescence. 
The negative control was incubated in the medium suitable for the cell line to be 
analysed without any additional carbohydrate. The pictures were taken with a 
fluorescence microscope (brightfield and the appropriate wavelength, 580 for TAMRA 
and 525 nm for fluorescein staining).The fluorescence microscopy image does not 
show any significant background fluorescence (figures 104 and 105). 
 
         
Figure 103 HEp-2 negative control w/o fed sugar (brightfield, left picture), TAMRA 
staining (580 nm, right picture) 
 
         
Figure 104 HEp-2 negative control w/o fed sugar (brightfield, left picture, 
fluorescein staining (525 nm, right picture). 
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The metabolic labelling of HEp-2 cells with GlcNAz was successful. We observed a 
clear alkynylated-TAMRA staining of the cell membrane in the expected wavelength 
(580 nm). However, also an unspecific staining of the nucleus membrane and some 
concentrated spots in the cytosol were visible. These may be glycoproteins in the ER, 
Golgi or endosomal vesicles containing our modified carbohydrates indicating an 
incorporation of the functionalised carbohydrates. Nevertheless our aim of cell 
membrane-functionalisation was achieved (figure 106). 
 
 
Figure 105 HEp-2 cells, 25 µM AcGlcNaz, 3 d, labelled with „Click-iT™ TAMRA 
(Tetramethylrhodamine) Glycoprotein Detection Kit“ (Invitrogen). Brightfield image on 
the left side, the right picture shows the alkynylated-TAMRA-stained cells at 580 nm. 
 
In a further experiment, the incorporation of the sialic acid analogue NeuNHex into 
HEp-2 cells was studied. Also that incorporation process and labelling reaction 
proved to be successful (figure 107). The labelling of the cell surface was performed 
with alkyne-functionalised fluorescein.  
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Figure 106 HEp-2 cells, 25 µM NeuNHex, 3 d, labelled with fluorescein azide. 
Brightfield image (right picture) and the fluorescein-labelled cell surface (525 nm, left 
picture). 
 
In order to show the broad possibilities of the method, we incorporated in on 
experiment the GlcNAz and in another experiment the NeuNHex into CHO-K1 cells. 
The labelling reaction was performed with alkyne- or azide-functionalised fluorescein, 
respectively, under the same reaction conditions (25 µM of the modified 
carbohydrate, click reaction with Cu(I), sodium ascorbate and TBTA as copper-
activating ligand). However, the results of this experiment are of minor quality 
regarding the cell membrane staining compared to the HEp-2 cells. This is most likely 
due to the staining click reaction which was performed over night. The click reaction 
proves best to be performed in between 1 h for optimal results. Another drawback of 
the reaction parameters and compounds used for the click reaction is the cytotpxicity 
of DMSO and copper. This problem for in vivo labelling can be overcome by different 
reaction conditions and different detection molecules. The strain-promoted click 
reaction with DIFO was introduced recently and proven to be suitable for in vivo 
labelling (Laughlin et al., 2008). 
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5 Summary 
Undoubtedly, carbohydrates play a crucial role in biological systems (Varki, 2006). 
They are involved in various processes like cell-cell recognition, tumour formation, 
inflammation and infections (Gruenberg et al., 2006; Varki, 2006). Unfortunately, 
carbohydrate patterns are not encoded in a biological system like proteins are in the 
DNA. Posttranslational modifications like methylation, acetylation, phosphorylation, 
sulfation and glycosylation are usually dynamic. Once a carbohydrate structure is 
identified as crucial for an infection process, the task is not over at all. Much effort 
was taken over the years to synthesise and analyse carbohydrate target structures 
without a significant breakthrough for glycobiology. The holy grail of glycoscience is a 
toolbox to synthesise any desired carbohydrate pattern. The main problem is the 
chemical similarity or even identity of many carbohydrates. Due to this difficult 
accessibility by chemical synthesis alone, new chemo-enzymatic methods are 
helping to expand the library of carbohydrate structures. The promiscuity of natural 
carbohydrate-transferring enzymes known as glycosyltransferases accompanied by 
enzyme and substrate engineering is a possibility for the synthesis of the target 
structures and their analogues (Chang et al., 2007; Lairson et al., 2008). The goal 
can only be achieved when biology, chemistry, process engineering and many other 
disciplines of life sciences work together. 
In this thesis, the synthesis and physiological analysis of biological-active tailor-made 
oligosaccharides is presented. Novel carbohydrate structures have been synthesised 
by a combination of enzyme and substrate engineering (Homann et al., 2009). The 
previously described physiological activity turned our focus on fructo-
oligosaccharides (Yun, 1996). As a first step, sucrose analogues were synthesised 
with the help of the fructosyltransferase SacB from Bacillus megaterium. This 
enzyme transfers the fructosyl moiety of sucrose to another monosaccharide of 
choice, e.g. galactose, mannose, xylose or fucose (Seibel et al., 2006b). These 
sucrose analogues act as substrates for another fructosyltransferase from Aspergillus 
niger (Zuccaro et al., 2008). By the consecutive action of these enzymes, 1-kestose 
and 1-nystose analogues with physiological functions were synthesised. In 
cooperation with the groups of Dieter Jahn (TU Braunschweig), Petra Dersch and 
Dirk Heinz (Helmholtz-Centre for Infection Research) the fructosyltransferases SacB 
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from B. megaterium and Suc1 from A. niger were identified, cloned, expressed, 
purified and characterised. Moreover, SacB from B. megaterium was crystallised and 
engineered to elucidate its transfructosylation mechanism for the synthesis of the 
oligosaccharide target structures. The two wild-type fructosyltransferases were 
screened for the acceptance of novel engineered substrate analogues synthesised in 
our group. Another point was the engineering of the enzymes to get functions 
exploitable for the synthesis of novel oligosaccharide structures. In order to elucidate 
the mechanism of transfructosylation, in cooperation with the group of Dieter Jahn, 
27 variants of the fructosyltransferase SacB from B. megaterium based on random 
screens and rational mutagenesis were created. The kinetic data as well as the 
product spectra of each variant gave new insights into the mechanism of fructosyl 
transfer. By these mutagenesis studies the fructosyltransferase from B. megaterium 
was engineered in order to produce tailor-made fructo-oligosaccharides of different 
degrees of polymerisation. The variants H423Y and K315A have a higher 
transfructosylation activity keeping the wild-types Km and kcat. New amino acid 
residues not located in the active site were identified as crucial for oligosaccharide 
synthesis (N252, K373, Y247). These studies lead to a generalised understanding of 
carbohydrate transfer mechanisms (figures 56 and 59). 
 
 
 
162 
 
Figure 56  Hydrolysis activity of the wild-type fructosyltransferase SacB from B. 
megaterium (WT) and its variants. Deviance from the wild-type in % (mol/mol). The 
carbohydrate concentrations were determined by HPAEC. 
 
Figure 59 Summary of the most important amino acid residues of the 
fructosyltransferase SacB from B. megaterium 
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The sucrose isomerase from Protaminobacter rubrum provides insights into another 
aspect of tailor-made oligosaccharides. By the native and engineered 
fructosyltransferases from B. megaterium and A. niger we got control over the degree 
of polymerisation. By substrate engineering of a sucrose isomerase from 
Protaminobacter rubrum we changed the linkage type of the sucrose analogue 
galactosylfructoside (Gal-Fru). The α-(1,2) bond of the sucrose analogue of Gal-Fru 
was shifted to an α-(1,6) linkage yielding an isomaltulose analogue of Gal-Fru 
(figures 60b and 70). The control of the linkage specificity is one important 
component to expand the library of accessible oligosaccharide structures for the 
synthesis of tailor-made oligosaccharides. 
 
 
Figure 60 B) The isomerisation reaction catalysed by the sucrose isomerase (SI) 
from P. rubrum with the sucrose analogue Gal-Fru (α-(1,2)-linkage) yielding the 
isomaltulose analogue (α-(1,6)-bound). 
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Figure 70 13C NMR spectrum of the α-/β-galactosylfructoside isomer synthesised 
by the sucrose isomerase from P. rubrum. 
 
The physiological functions of the short-chain oligosaccharides were investigated in 
an assay with a human epithelial colorectal adenocarcinoma cell line (Caco-2). Their 
cytokine release pattern was characterised. The novel fructo-oligosaccharides 
synthesised by the concerted action of the two fructosyltransferases from B. 
megaterium and A. niger showed remarkable immuno-stimulating properties (figure 
71). The chemokine MCP-1 was clearly triggered when Caco-2 cells are incubated in 
the presence of the novel fructo-oligosaccharides. The 1-nystose analogues MF3 and 
FF3 with exposed mannosyl and fucosyl moieties show an enhancement in the 
release of MCP-1 by factor 2.72 and 2.58, respectively (figure 97). 
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Figure 71 Fructo-oligosaccharide target structures. I) Established product on the 
market (1-kestose and 1-nystose). II) 1-kestose (Man-(Fru2) or 1-nystose (Man-(Fru3) 
analogue, III) 1-kestose (Gal-(Fru)2) or nystose (Gal-(Fru)3) analogue. IV) 1-kestose 
(Fuc-(Fru)2) or 1-nystose (Fuc-(Fru)3) analogue. V) 1-kestose (Xyl-(Fru)2) or 1-
nystose (Xyl-(Fru)3) analogue. 
 
MCP-1 
 
Figure 97 Factors of signal-to-background enhancement of the MCP-1 
concentration. 
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In the last step towards tailor-made oligosaccharides and the investigation of their 
physiological properties, the application of chemically modified carbohydrates further 
broadens the product spectrum of glycosyltransferases and paves the way for novel 
biological applications and strategies. One example of a combined chemo-enzymatic 
strategy of bioorthogonal metabolic labelling is the so-called click chemistry. Huisgen 
and Sharpless developed a bioorthogonal, very specific quantitatively (1,3)-triazole 
formation of an azide and an alkyne group (Kolb et al., 2001). Enzymes of the 
eukaryotic and human carbohydrate metabolism accept various functionalised 
monosaccharides as substrates in vitro and in vivo (Prescher et al., 2006; Baskin et 
al., 2007; Chang et al., 2007). These modified carbohydrates are incorporated into 
glycoproteins and glycolipids (figure 102). The functionalised carbohydrate motifs can 
now be specifically addressed (Laughlin et al., 2009). In this work, HEp-2 cells with 
specifically functionalised carbohydrates (GlcNAz, AcGlcNAz, NeuNAz and 
NeuNHEx) were tagged. After incorporation into the target cell line they were labelled 
with functionalised fluorescein or tetramethylrhodamine (TAMRA), respectively (figure 
105). So basically all of the aims of this thesis have been achieved. 
 
 
Figure 102 Incorporation of modified carbohydrates into the natural carbohydrate 
metabolic process of eukaryotic cells. 
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Figure 105 HEp-2 cells, 25 µM AcGlcNaz, 3 d, labelled with „Click-iT™ TAMRA 
(Tetramethylrhodamine) Glycoprotein Detection Kit“ (Invitrogen). Brightfield image on 
the left side, the right picture shows the alkynylated-TAMRA-stained cells at 580 nm. 
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